Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2824381B2 - N- (cycloalkyl) alkylazepine derivatives and method for producing the same - Google Patents
[go: Go Back, main page]

JP2824381B2 - N- (cycloalkyl) alkylazepine derivatives and method for producing the same - Google Patents

N- (cycloalkyl) alkylazepine derivatives and method for producing the same

Info

Publication number
JP2824381B2
JP2824381B2 JP22374593A JP22374593A JP2824381B2 JP 2824381 B2 JP2824381 B2 JP 2824381B2 JP 22374593 A JP22374593 A JP 22374593A JP 22374593 A JP22374593 A JP 22374593A JP 2824381 B2 JP2824381 B2 JP 2824381B2
Authority
JP
Japan
Prior art keywords
group
added
yield
trimethyl
azabicyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP22374593A
Other languages
Japanese (ja)
Other versions
JPH06172315A (en
Inventor
信幸 高橋
大介 望月
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Corp filed Critical Asahi Kasei Corp
Priority to JP22374593A priority Critical patent/JP2824381B2/en
Publication of JPH06172315A publication Critical patent/JPH06172315A/en
Application granted granted Critical
Publication of JP2824381B2 publication Critical patent/JP2824381B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明はシグマレセプターに特異
的に結合する活性を有する新規アゼピン誘導体およびそ
の製造法に関する。
BACKGROUND OF THE INVENTION The present invention is novel azepine induction bodies and their having an activity of specifically binding to the sigma receptor
A method for producing the same .

【0002】[0002]

【従来の技術】シグマ(σ)レセプターは、元来、μ、
δ、κ、εレセプターと共にオピオイドレセプターの一
つとして定義されていた。しかし、オピオイド拮抗薬で
あるナロキソン(Naloxon)がσレセプターに対
して親和性をもたないことから、最近では、オピオイド
レセプターではなく独立したレセプターとして分類され
ている。
2. Description of the Related Art The sigma (σ) receptor is originally μ,
It was defined as one of the opioid receptors together with the δ, κ, and ε receptors. However, since naloxone, an opioid antagonist, has no affinity for the σ receptor, it has recently been classified as an independent receptor rather than an opioid receptor.

【0003】σレセプターを介する薬理作用は未だ解明
されていない。しかしながら、精神異常発現作用を有す
るフェンシクリジン(Phencyclidine)が
NMDAレセプター以外にσレセプターにも親和性を有
していることや抗精神分裂病薬であるハロペリドール
(Haloperidol)がドパミンレセプター以外
にσレセプターにも強く結合することが明らかとなって
いる。これらのことから、σレセプターは精神機能に関
与している可能性が示唆されている。しかしながらσレ
セプターに対して特異的な薬物はほとんど報告されてい
ない。
[0003] The pharmacological action via the sigma receptor has not yet been elucidated. However, the fact that phencyclidine, which has a psychiatric manifestation effect, has an affinity not only for the NMDA receptor but also for the σ receptor, and that the antischizophrenic drug haloperidol is used for the σ receptor in addition to the dopamine receptor It has also been found that they bind strongly. These facts suggest that the σ receptor may be involved in mental functions. However, few drugs specific to the sigma receptor have been reported.

【0004】英国特許852971(1959)明細
書、Acta pharmacol.et toxic
ol.,17,277〜287(1960)およびAc
taChemica Scandinavica,1
7,2069〜2078(1963)には、一般式
[0004] British Patent 852971 (1959), Acta Pharmacol. et toxic
ol. , 17, 277-287 (1960) and Ac
taChemica Scandinavica, 1
7, 2069 to 2078 (1963) have the general formula

【0005】[0005]

【化11】 (式中、R1 、R2 、R3 およびR4 はH、Cl、−N
2 、−NH2 、−CH3 、−OCH3 または−OH基
を示し、は1〜3の整数を示す。)で表されるN−置
換フェニルアルキルカンフィジン誘導体が開示され、中
枢神経系抑制薬(depressor activit
y upon the centralnervous
system)およびトランキライザーとして有用で
あることが記載されている。
Embedded image (Wherein R 1 , R 2 , R 3 and R 4 are H, Cl, -N
O 2, -NH 2, -CH 3 , shows a -OCH 3 or -OH group, m is an integer of 1-3. N-substituted phenylalkyl camfidine derivatives represented by the following formulas are disclosed, and depressor activators
y upon the centralnervous
systems) and tranquilizers.

【0006】また、薬学雑誌、84(10),918〜
929(1964)には、一般式
Also, Pharmaceutical Magazine, 84 (10), 918-
929 (1964) has the general formula

【化12】 Embedded image

【0007】(式中、R’はH、Clまたは−NH2
を示し、は1または2を示す。)で表されるN−置換
フェニルアルキルカンフィジン誘導体が開示され、鎮痛
作用について検討されたが、あまり効果はなかったと報
告されている。しかしながら、上記のいずれの先行文献
においても、これらの公知化合物は、精神分裂病の動物
モデルとして汎用されているアポモルヒネ誘発クライミ
ングモデルでの有用性は全く記載はない。
Wherein R ′ is H, Cl or —NH 2 group and m is 1 or 2. An N-substituted phenylalkylcamphidine derivative represented by the formula: It was considered but reportedly not effective. However, none of the above-mentioned prior art documents describes the usefulness of these known compounds in an apomorphine-induced climbing model widely used as an animal model of schizophrenia.

【0008】[0008]

【発明が解決しようとする課題】σレセプターに対し特
異的な薬物が見出され、その薬効の発見が新しいタイプ
の薬物を開発する上で重要なことである。
DISCLOSURE OF THE INVENTION A drug specific to a sigma receptor has been found, and the discovery of its efficacy is important in developing a new type of drug.

【0009】[0009]

【課題を解決するための手段】本発明者らは、種々の化
合物を合成し、それらの薬理作用について広く検索して
いたところ、下記の一般式(1)で示されるアゼピン誘
導体が、σレセプターに対し高い親和性をもち、他のレ
セプターに対しては殆ど親和性を示さず、また抗精神分
裂病の評価に使用されているアポモルヒネ誘発クライミ
ングの抑制作用に対して有効性を示した。本発明は、上
記の知見に基づいて完成されたものである。
Means for Solving the Problems The present inventors have synthesized various compounds and searched widely for their pharmacological actions. As a result, the azepine derivative represented by the following general formula (1) was converted to a sigma receptor. Showed high affinity for other receptors and showed little effect on the inhibitory effect of apomorphine-induced climbing used in the evaluation of anti-schizophrenia. The present invention has been completed based on the above findings.

【0010】すなわち、本発明は、一般式That is, the present invention provides a compound represented by the general formula

【化13】 〔式中、Rは式Embedded image [Wherein R is a formula

【化14】 (式中、R1 は水素原子、低級アルキル基、低級アルコ
キシ基、水酸基、ハロゲン原子または置換基を有してい
てもよいフェニル基を示し、nは0または1を示す)で
表される基、低級アルキル基で置換していてもよい炭素
数5〜8個のシクロアルキル基、ノルボルニル基または
ビシクロ[3.3.1]ノニル基を示し、mは0〜4の
整数を示し、C* は不斉炭素原子を示す〕で表されるア
ゼピン誘導体またはその塩を提供するものである。
Embedded image (Wherein, R 1 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group, a halogen atom or a phenyl group which may have a substituent, and n represents 0 or 1) a lower alkyl group substituted with an optionally several 5-8 cycloalkyl group having a carbon also shows a norbornyl group or a bicyclo [3.3.1] nonyl group, m represents an integer of 0 to 4, C * Represents an asymmetric carbon atom], or a salt thereof.

【0011】また、本発明は、一般式Further, the present invention provides a compound represented by the following general formula:

【化15】 〔式中、C* は不斉炭素原子を示し、pは0〜3の整数
を示し、Rは前記と同じ意味を有する)で表される化合
物のカルボニル基を還元することを特徴とするか、ある
いは一般式
Embedded image Wherein C * represents an asymmetric carbon atom, p represents an integer of 0 to 3, and R has the same meaning as described above. Or the general formula

【0012】[0012]

【化16】 (式中、C* は不斉炭素原子を示す)で表されるアミン
と一般式 X−(CH2 )m−R (5) (式中、Xは反応性有機スルホニルオキシ基またはハロ
ゲン原子を示し、mは0〜4の整数を示し、Rは前記と
同じ意味を有する)で表される反応性誘導体を不活性有
機溶媒中、塩基の存在下で反応させることを特徴とする
前記一般式(1)で表されるアゼピン誘導体またはその
塩を提供するものである。
Embedded image (Wherein, C * is an asymmetric carbon atom) amine of the general formula X- (CH 2) m-R (5) ( wherein, represented by, X is a reactive organic sulfonyloxy group or a halogen atom Wherein m is an integer of 0 to 4, and R has the same meaning as described above), wherein the reactive derivative represented by the general formula is reacted in an inert organic solvent in the presence of a base. An object of the present invention is to provide an azepine derivative represented by (1) or a salt thereof.

【0013】さらに、本発明は、前記一般式(1)で表
されるアゼピン誘導体またはその塩の中間体として有用
な前記一般式(3)で表されるアゼピン誘導体およびそ
の塩を提供するものである。
Further , the present invention provides an azepine derivative represented by the general formula (3) and a salt thereof useful as an intermediate of the azepine derivative represented by the general formula (1) or a salt thereof. is there.

【0014】前記一般式(1)において定義される基R
としては、水素原子、低級アルキル基、低級アルコキシ
基、水酸基、ハロゲン原子または置換基を有していても
よいフェニル基置換されたアダマンチル基またはノル
アダマンチル基が挙げられる。上記の置換基はアダマン
タン環およびノルアダマンタン環中のいずれの位置の炭
素原子に置換されていてもよい。低級アルキル基とは炭
素数1〜4個の分鎖を有していてもよいアルキル基を意
味し、低級アルコキシ基とは炭素数1〜4個の分鎖を有
していてもよいアルコキシ基を意味し、ハロゲン原子と
は塩素原子、臭素原子、弗素原子などを意味し、置換基
を有していてもよいフェニル基とは1〜3個の低級アル
キル基、低級アルコキシ基、水酸基またはハロゲン原子
で置換されていてもよいフェニル基を意味する。アダマ
ンタン基およびノルアダマンタン基の基−(CH2 )m
−との結合位置は該環中のいずれの位置の炭素原子と結
合していてもよい。
The group R defined in the general formula (1)
Examples thereof include a hydrogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group, an adamantyl group or a noradamantyl group substituted with a halogen atom or a phenyl group which may have a substituent. The above substituent may be substituted on a carbon atom at any position in the adamantane ring and the noradamantane ring. A lower alkyl group means an alkyl group which may have a branched chain having 1 to 4 carbon atoms, and a lower alkoxy group means an alkoxy group which may have a branched chain having 1 to 4 carbon atoms. And a halogen atom means a chlorine atom, a bromine atom, a fluorine atom and the like, and a phenyl group which may have a substituent means 1 to 3 lower alkyl groups, lower alkoxy groups, hydroxyl groups or halogens. A phenyl group which may be substituted with an atom is meant. Group adamantane group and noradamantane group - (CH 2) m
The bonding position with-may be bonded to a carbon atom at any position in the ring.

【0015】他の基Rとしては、低級アルキル基で置換
していてもよい炭素数5〜8個のシクロアルキル基、ノ
ルボルニル基、ビシクロ[3.3.1]ノニル基が挙げ
られる。ノルボルニル基およびビシクロ[3.3.1]
ノニル基−(CH2 )m−との結合位置は該環中のい
ずれの位置の炭素原子と結合していてもよい。炭素数5
〜8個のシクロアルキル基の例としてはシクロペンチ
ル、シクロヘキシル、シクロプチルおよびシクロオク
チル基が挙げられ、低級アルキル基とは炭素数1〜4個
の分鎖を有していてもよいアルキル基を意味する。
Examples of the other group R include a cycloalkyl group having 5 to 8 carbon atoms which may be substituted with a lower alkyl group, a norbornyl group, and a bicyclo [3.3.1] nonyl group. Norbornyl group and bicyclo [3.3.1]
Nonyl group and a - (CH 2) bonding site to the m- may be attached to a carbon atom of any position in the ring. Carbon number 5
8 pieces of cyclopentyl Examples of cycloalkyl groups include cyclohexyl, include cycloheptyl and cyclooctyl groups cycloheteroalkyl, a lower alkyl group and the alkyl group which may have 1 to 4 branched chain atoms means.

【0016】本発明のアゼピン誘導体(1)およびその
塩は、次の方法により製造される。A).化合物(3)
のカルボニル基の還元による一般式(1)におけるmが
1〜4である目的化合物(1)、すなわち一般式
The azepine derivative (1) of the present invention and a salt thereof are produced by the following method. A). Compound (3)
Target compound (1) wherein m in the general formula (1) is 1 to 4 by reduction of a carbonyl group of

【化17】 (C* は不斉炭素原子を示し、pは0〜3の整数を示
し、Rは前記と同じ意味を有する)で表される目的化合
物(1a)の製造
Embedded image (C * represents an asymmetric carbon atom, p represents an integer of 0 to 3, and R has the same meaning as described above).

【0017】前記化合物(3)は、前記一般式(4)で
表されるアミンを一般式 R−(CH2 )p−COOH (6) (式中、pは0〜3の整数を示し、Rは前記と同じ意味
を有する)で表されるカルボン酸またはその反応性誘導
体でアシル化することにより得られる。
The compound (3) is obtained by converting the amine represented by the general formula (4) into a general formula R- (CH 2 ) p-COOH (6) (where p represents an integer of 0 to 3, R has the same meaning as described above) or a acyl derivative thereof, or a reactive derivative thereof.

【0018】上記の出発原料のうち、一般式(4)で示
されるアミン、すなわち1,8,8−トリメチル−3−
アザビシクロ[3.2.1]オクタンは一般式(4)で
示される如く不斉炭素原子を有するので、R体または
S体の光学活性体として使用される。R体は文献記
載の公知化合物であって、例えば、Acta.Che
m.Scand.,17,2069(1963)、Te
trahedron Letters,21,4593
(1980)などの文献に記載されている。S体は文
献未載の化合物であって、(1S)−1,8,8−トリ
メチル−3−アザビシクロ[3.2.1]オクタン−2
−オンを不活性有機溶媒中水素化リチウムアルミニウム
などの還元剤で還元することにより得られる。
Of the above starting materials, the amine represented by the general formula (4), that is, 1,8,8-trimethyl-3-
Since azabicyclo [3.2.1] octane has an asymmetric carbon atom as represented by the general formula (4), 1 R, or
It is used as an optically active substance of the 1 S form. The 1R-form is a known compound described in the literature, for example, Acta. Che
m. Scand. , 17, 2069 (1963), Te
Trahedron Letters, 21, 4593
(1980). The 1 S form is a compound not described in the literature, and is (1S) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane-2.
-One is reduced by a reducing agent such as lithium aluminum hydride in an inert organic solvent.

【0019】一方、一般式(6)で示されるカルボン酸
の好適な例としては、1−アダマンチル酢酸、2−アダ
マンチル酢酸、3−メチル−1−アダマンチル酢酸、1
−アダマンタンカルボン酸、2−アダマンチル−3−プ
ロピオン酸、2−アダマンチル−4−酪酸、3−ノルア
ダマンタンカルボン酸、2−ノルボルニル酢酸、9−ビ
シクロ[3.3.1]ノニル酢酸、シクロヘキサンカル
ボン酸、シクロペンタンカルボン酸、シクロペンチル酢
酸、シクロヘキシル酢酸、シクロへプチル酢酸、シクロ
オクチル酢酸、3−シクロヘキシルプロピオン酸、4−
シクロヘキシル酪酸、4−メチルシクロヘキシル酢酸、
5−ヒドロキシ−2−アダマンチル酢酸、5−メトキシ
−2−アダマンチル酢酸、5−フェニル−2−アダマン
チル酢酸、4−ヒドロキシ−2−アダマンチル酢酸、4
−フェニル−2−アダマンチル酢酸などが挙げられる。
これらの多くは公知の化合物であり、それぞれ市販品ま
たは合成により容易に入手可能である。
On the other hand, preferred examples of the carboxylic acid represented by the general formula (6) include 1-adamantyl acetic acid, 2-adamantyl acetic acid, 3-methyl-1-adamantyl acetic acid,
-Adamantanecarboxylic acid, 2-adamantyl-3-propionic acid, 2-adamantyl-4-butyric acid, 3-noradamantancarboxylic acid, 2-norbornylacetic acid, 9-bicyclo [3.3.1] nonylacetic acid, cyclohexanecarboxylic acid , Cyclopentanecarboxylic acid, cyclopentylacetic acid, cyclohexylacetic acid, cycloheptylacetic acid, cyclooctylacetic acid, 3-cyclohexylpropionic acid, 4-
Cyclohexyl butyric acid, 4-methyl-cyclo-hexyl acetate,
5-hydroxy-2-adamantyl acetic acid, 5-methoxy-2-adamantyl acetic acid, 5-phenyl-2-adamantyl acetic acid, 4-hydroxy-2-adamantyl acetic acid, 4
-Phenyl-2-adamantylacetic acid and the like.
These In many are known compounds, it is readily available by the respective commercially or synthesized.

【0020】上記のアシル化反応は、公知のアミド化反
応に準じて実施することができる。カルボン酸(6)を
遊離の形で使用する場合には、縮合剤の存在下で反応を
行わせる。その縮合剤の例としては、N,N’−ジシク
ロヘキシルカルボジイミド(DCC)、1−エチル−3
−(3’−ジメチルアミノプロピル)カルボジイミド
(WSC)、N−シクロヘキシル−N’−(4−ジエチ
ルアミノシクロヘキシル)カルボジイミドなどのカルボ
ジイミド化合物、ジフェニルホスホリルアジド、ベンゾ
トリアゾリル−N−ヒドロキシトリス(ジメチルアミ
ノ)ホスホニウムヘキサフルオロリン化物塩、カルボニ
ルジイミダゾールなどの試薬、N−メチルホルムアミ
ド、N,N−ジメチルホルムアミドなどのアミド化合物
を塩化チオニル、オキシ塩化リン、ホスゲンなどのハロ
ゲン化物との反応によって生成する試薬(いわゆるビル
スマイヤー試薬)などが挙げられる。その他の公知の縮
合剤も使用できる。
The above-mentioned acylation reaction can be carried out according to a known amidation reaction. When the carboxylic acid (6) is used in a free form, the reaction is carried out in the presence of a condensing agent. Examples of the condensing agent include N, N'-dicyclohexylcarbodiimide (DCC), 1-ethyl-3
Carbodiimide compounds such as-(3'-dimethylaminopropyl) carbodiimide (WSC), N-cyclohexyl-N '-(4-diethylaminocyclohexyl) carbodiimide, diphenylphosphoryl azide, benzotriazolyl-N-hydroxytris (dimethylamino) Reagents such as phosphonium hexafluorophosphide salts and carbonyldiimidazole, and reagents for producing amide compounds such as N-methylformamide and N, N-dimethylformamide by reaction with halides such as thionyl chloride, phosphorus oxychloride and phosgene ( So-called Vilsmeier reagent). Other known condensing agents can also be used.

【0021】カルボン酸(6)の反応性誘導体として
は、その酸ハライド、酸無水物、酸アジド、活性エステ
ル、活性アミドなどが挙げられ、その好ましい例として
は、酸クロライド、酸ブロマイド、酢酸、ピバリン酸、
イソ吉草酸、トリクロロ酢酸、炭酸モノアルキルエステ
ルなどとの混合酸無水物、p−ニトロフェニルエステ
ル、2,4−ジニトロフェニルエステル、トリクロロフ
ェニルエステル、ペンタクロロフェニルエステル、1−
ヒドロキシ−1H−ピリドン、N−ヒドロキシスクシン
イミドエステル、N−ヒドロキシフタルイミドエステル
などの活性エステル、ピラゾール、イミダゾール、ジメ
チルピラゾール、ベンゾトリアゾールなどの活性アミド
などが挙げられる。
Examples of the reactive derivative of the carboxylic acid (6) include acid halides, acid anhydrides, acid azides, active esters, and active amides. Preferred examples thereof include acid chloride, acid bromide, acetic acid, and the like. Pivalic acid,
Mixed acid anhydrides with isovaleric acid, trichloroacetic acid, monoalkyl carbonate, etc., p-nitrophenyl ester, 2,4-dinitrophenyl ester, trichlorophenyl ester, pentachlorophenyl ester, 1-
Active esters such as hydroxy-1H-pyridone, N-hydroxysuccinimide ester and N-hydroxyphthalimide ester, and active amides such as pyrazole, imidazole, dimethylpyrazole and benzotriazole are exemplified.

【0022】上記アシル化反応における反応性誘導体の
中で、酸ハロゲン化物または酸無水物を用いる反応は脱
酸剤の存在下で行うのが好ましい。脱酸剤としては、例
えばトリエチルアミン、エチルジイソプロピルアミン、
N,N−ジメチルアニリン、N−メチルモルホリン、ピ
リジンなどの第3級有機塩基や公知の無機塩基が使用さ
れる。
The reaction using an acid halide or an acid anhydride among the reactive derivatives in the above acylation reaction is preferably carried out in the presence of a deoxidizing agent. Examples of the deoxidizing agent include triethylamine, ethyldiisopropylamine,
Tertiary organic bases such as N, N-dimethylaniline, N-methylmorpholine, and pyridine and known inorganic bases are used.

【0023】アミン(4)とカルボン酸(6)またはそ
の反応性誘導体との量的割合は、理論的には等モルでよ
いが、通常はカルボン酸(6)またはその反応性誘導体
が過剰に用いられる。
The quantitative ratio of the amine (4) to the carboxylic acid (6) or its reactive derivative may theoretically be equimolar, but usually the carboxylic acid (6) or its reactive derivative is in excess. Used.

【0024】上記アシル化反応は、反応に悪影響を及ぼ
さないような有機溶媒中で行われ、有機溶媒としては、
クロロホルム、塩化メチレン、テトラヒドロフラン、
1,4−ジオキサン、N,N−ジメチルホルムアミド、
N,N−ジメチルアセトアミド、アセトンまたはこれら
の混合溶媒などが使用される。反応温度は特に限定され
ないが、通常は室温で充分に進行する。反応時間は、反
応温度、カルボン酸(6)またはその反応性誘導体の種
類により左右され、一般には特定できないが、精々48
時間程度迄である。
The above-mentioned acylation reaction is carried out in an organic solvent which does not adversely affect the reaction.
Chloroform, methylene chloride, tetrahydrofuran,
1,4-dioxane, N, N-dimethylformamide,
N, N-dimethylacetamide, acetone or a mixed solvent thereof is used. The reaction temperature is not particularly limited, but usually proceeds sufficiently at room temperature. The reaction time depends on the reaction temperature and the type of the carboxylic acid (6) or a reactive derivative thereof, and cannot be generally specified.
It is up to about an hour.

【0025】上記アシル化反応によって得られた化合物
(3)を反応液から採取するには、反応溶媒が非親水性
有機溶媒である場合には、反応液をアルカリ性水溶液、
酸性水溶液または飽和食塩水で洗浄した後、有機溶媒層
を濃縮し、反応溶媒が親水性有機溶媒である場合には、
該溶媒を留去し、残渣を非親水性有機溶媒に溶解した
後、前記と同様に処理することにより化合物(3)を得
ることができる。該化合物(3)を、さらに、例えば、
カラムクロマトグラフィー、再結晶などの公知の精製法
により精製することができる。
In order to collect the compound (3) obtained by the acylation reaction from the reaction solution, when the reaction solvent is a non-hydrophilic organic solvent, the reaction solution is treated with an alkaline aqueous solution.
After washing with an acidic aqueous solution or a saturated saline solution, the organic solvent layer is concentrated, and when the reaction solvent is a hydrophilic organic solvent,
The solvent is distilled off, the residue is dissolved in a non-hydrophilic organic solvent, and the mixture is treated in the same manner as described above to obtain compound (3). The compound (3) is further, for example,
It can be purified by a known purification method such as column chromatography and recrystallization.

【0026】本発明においては、化合物(3)のカルボ
ニル基を還元して本発明化合物(1a)を得るのである
が、上記の反応は化合物(3)を不活性有機溶媒中、水
素化リチウムアルミニウム、水素化ナトリウムアルミニ
ウム、水素化ホウ素などの還元剤で還元することにより
行われる。不活性有機溶媒の例としてはテトラヒドロフ
ラン、ジエチルエーテル、1,4−ジオキサン、ピリジ
ンなどが挙げられる。反応温度は通常、加熱下、できれ
ば還流下で行われる。反応時間は、反応温度、還元剤の
種類により左右されるが、薄層クロマトグラフィー、高
速液体クロマトグラフィーなどにより反応の経過を追跡
することができるので、化合物(3)の消失を待って反
応を終了させればよい。一般には特定できないが、1〜
10時間程度である。
In the present invention, the compound (3a) is reduced by reducing the carbonyl group of the compound (3) to obtain the compound (1a) of the present invention. , Sodium aluminum hydride, borohydride and the like. Examples of the inert organic solvent include tetrahydrofuran, diethyl ether, 1,4-dioxane, pyridine and the like. The reaction is usually carried out with heating, preferably at reflux. The reaction time depends on the reaction temperature and the type of the reducing agent, but the progress of the reaction can be monitored by thin-layer chromatography, high performance liquid chromatography, etc. It should just end. Although it cannot be specified in general,
It takes about 10 hours.

【0027】上記還元反応によって得られた目的化合物
(1a)を反応液から採取するには、反応溶媒が非親水
性有機溶媒である場合には、反応液を酸性水溶液、アル
カリ性水溶液、または飽和食塩水で洗浄した後、有機溶
媒層を濃縮し、反応溶媒が親水性有機溶媒である場合に
は、該溶媒を留去し、更に必要に応じて残渣を非親水性
有機溶媒に溶解した後、前記と同様に処理することによ
り化合物(1a)を得ることができる。該化合物(1
a)を、さらに、例えば、カラムクロマトグラフィー、
再結晶などの公知の精製法により精製することができ
る。
In order to collect the target compound (1a) obtained by the above reduction reaction from the reaction solution, when the reaction solvent is a non-hydrophilic organic solvent, the reaction solution is treated with an acidic aqueous solution, an alkaline aqueous solution, or a saturated saline solution. After washing with water, the organic solvent layer is concentrated, and when the reaction solvent is a hydrophilic organic solvent, the solvent is distilled off and, if necessary, the residue is dissolved in a non-hydrophilic organic solvent. Compound (1a) can be obtained by treating in the same manner as described above. The compound (1
a) is further treated, for example, by column chromatography,
It can be purified by a known purification method such as recrystallization.

【0028】B).アミン(4)のN−アルキル化によ
る目的化合物(1)の製造 目的化合物(1)は、一般式
B). Production of target compound (1) by N-alkylation of amine (4) The target compound (1) is represented by the general formula

【化18】 式中、C * は不斉炭素原子を示す)で表されるアミン
と一般式 X−(CH2 m −R (5) (式中、Xは反応性有機スルホニルオキシ基またはハロ
ゲン原子を示し、mは0〜4の整数を示し、Rは前記と
同じ意味を有する)で表される反応性誘導体を不活性有
機溶媒中、塩基の存在下で反応させることにより得られ
る。
Embedded image ( Wherein C * represents an asymmetric carbon atom)
And X- (CH 2 ) m -R (5) (wherein, X represents a reactive organic sulfonyloxy group or a halogen atom, m represents an integer of 0 to 4, and R has the same meaning as described above.) ) In an inert organic solvent in the presence of a base.

【0029】上記反応性誘導体(5)のうちスルホニル
オキシ誘導体は、一般式 HO−(CH2 )m−R (7) (mは0〜4の整数を示す)で表されるアルコールを塩
化メチレンのような乾燥不活性反応溶媒中、メタンスル
ホニルクロライド、p−トルエンスルホニルクロライド
などでスルホニル化することにより得られる。上記のア
ルコール(7)の例としては、1−アダマンチルエタノ
−ル、1−アダマンチルメタノール、2−アダマンチル
エタノ−ル、2−ノルボルニルエタノール、3−ノルア
ダマンチルメタノール、9−ビシクロ[3.3.1]ノ
ニルエタノール、シクロペンチルアルコール、シクロヘ
キシルアルコール、シクロペンチルメタノール、シクロ
ヘキシルメタノール、シクロヘプチルメタノール、シク
ロオクチルメタノール、シクロペンチルエタノール、シ
クロヘキシルエタノール、シクロペンチルエタノ−ル、
3−シクロヘキシル−1−プロパノ−ル、4−シクロヘ
キシル−1−ブタノール、5−メトキシ−2−アダマン
チルエタノ−ル、5−クロロ−2−アダマンチルエタノ
−ル、5−フェニル−2−アダマンチルエタノ−ル、4
−フェニル−2−アダマンチルエタノ−ルなどが挙げら
れる。これらは公知の化合物であり、それぞれ市販品ま
たは合成により容易に入手可能である。
Among the reactive derivatives (5), the sulfonyloxy derivative is obtained by converting an alcohol represented by the general formula HO— (CH 2 ) m—R (7) (m is an integer of 0 to 4) into methylene chloride drying reaction inert solvent such as, methanesulfonyl chloride, Ru obtained by sulfonylating the like p- toluenesulfonyl chloride. The example above alcohol (7), 1-adamantyl ethanone nor, 1-adamantyl methanol, 2-adamantyl eth-nor, 2-norbornyl ethanol, 3-noradamantyl methanol, 9-bicyclo [3. 3.1] Nonylethanol, cyclopentyl alcohol, cyclohexyl alcohol, cyclopentylmethanol, cyclohexylmethanol, cycloheptylmethanol, cyclooctylmethanol, cyclopentylethanol, cyclohexylethanol, cyclopentylethanol,
3-cyclohexyl-1-propanol, 4-cyclohexyl-1-butanol, 5-methoxy-2-adamantylethanol, 5-chloro-2-adamantylethanol, 5-phenyl-2-adamantylethanol , 4
-Phenyl-2-adamantylethanol and the like. These are known compounds, each of which is commercially available or easily available by synthesis.

【0030】また、上記反応性誘導体(5)のうちハロ
ゲン化物としては、シクロヘキシルブロマイド、シクロ
ヘキシルメチルブロマイド、1−アダマンチルブロマイ
ド、2−アダマンチルブロマイドなどが挙げられる。こ
れらは公知の化合物であり、試薬メーカーのカタログに
掲載されている化合物であって、容易に入手可能であ
る。
Examples of the halide in the reactive derivative (5) include cyclohexyl bromide, cyclohexylmethyl bromide, 1-adamantyl bromide and 2-adamantyl bromide. These are known compounds and are listed in the catalogs of reagent manufacturers and are readily available.

【0031】アミン(4)と反応性誘導体(5)との反
応で使用される塩基の例としては、例えば、トリエチル
アミン、エチルジイソプロピルアミン、N,N−ジメチ
ルアニリン、N−メチルモルホリン、ピリジン、N,N
−ジメチルアミノピリジンなどの第3級有機塩基やアル
カリまたはアルカリ土類金属の炭酸塩、炭酸水素塩、水
酸化物または水素化物などの無機塩基が挙げられる。
Examples of the base used in the reaction of the amine (4) with the reactive derivative (5) include, for example, triethylamine, ethyldiisopropylamine, N, N-dimethylaniline, N-methylmorpholine, pyridine, N , N
Tertiary organic bases such as dimethylaminopyridine and inorganic bases such as carbonates, bicarbonates, hydroxides or hydrides of alkali or alkaline earth metals.

【0032】上記反応において使用される不活性有機溶
媒の例としては、アセトニトリル、ベンゼン、アセト
ン、テトラヒドロフランなどが挙げられるが、アセトニ
トリルが特に好ましい。上記反応は通常、使用する反応
溶媒の還流温度で適宜行われる。反応時間は、反応温
度、塩基の種類により左右されるが、薄層クロマトグラ
フィー、高速液体クロマトグラフィーなどにより反応の
経過を追跡することができるので、化合物(4)の消失
を待って適宜反応を終了させればよい。一般には特定で
きないが、通常は2〜72時間程度である。
Examples of the inert organic solvent used in the above reaction include acetonitrile, benzene, acetone, tetrahydrofuran and the like, and acetonitrile is particularly preferred. The above reaction is usually performed appropriately at the reflux temperature of the reaction solvent used. The reaction time depends on the reaction temperature and the type of base, but the progress of the reaction can be monitored by thin layer chromatography, high performance liquid chromatography, etc. It should just end. Although it cannot be generally specified, it is usually about 2 to 72 hours.

【0033】上記反応液から目的化合物(1)を得るに
は、不溶性物を濾去し、溶媒を濃縮した後、残渣を例え
ば、クロロホルムとアセトンやメタノールとの混合物を
溶離剤としてシリカゲルカラムクロマトグラフィーなど
の公知の精製法により精製することができる。本発明に
おいては、本発明化合物(1)が開示されれば、上記で
示した製造法に限らず、公知の反応を組み合わせること
により製造することは容易である。
In order to obtain the desired compound (1) from the above reaction mixture, insoluble substances are removed by filtration, the solvent is concentrated, and the residue is subjected to silica gel column chromatography using, for example, a mixture of chloroform, acetone and methanol as an eluent. It can be purified by a known purification method such as In the present invention, as long as the compound (1) of the present invention is disclosed, it is easy to produce by combining known reactions, not limited to the production method described above.

【0034】このようにして得られた本発明化合物
(1)は、塩とすることができ、必要に応じてその医薬
上許容される無毒性塩とすることも可能である。このよ
うな塩の例としては、塩酸、硫酸、リン酸などの無機酸
との塩、酢酸、プロピオン酸、酒石酸、クエン酸、グリ
コール酸、グルコン酸、コハク酸、リンゴ酸、グルタミ
ン酸、アスパラギン酸、メタンスルホン酸、マンデル
酸、p−トルエンスルホン酸、マレイン酸などの有機酸
との酸付加塩を挙げることができる。
The compound (1) of the present invention thus obtained can be converted into a salt, and if necessary, a pharmaceutically acceptable non-toxic salt. Examples of such salts include salts with inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid, propionic acid, tartaric acid, citric acid, glycolic acid, gluconic acid, succinic acid, malic acid, glutamic acid, aspartic acid, Examples thereof include acid addition salts with organic acids such as methanesulfonic acid, mandelic acid, p-toluenesulfonic acid, and maleic acid.

【0035】本発明化合物(1)またはその無毒性塩の
いずれの化合物もラットに30mg/kg静脈投与して
も、死亡例は認められなかったことから明かなように、
医薬として使用しても安全な化合物ということができ
る。
As is clear from the fact that no death was observed when the compound (1) of the present invention or a non-toxic salt thereof was intravenously administered to rats at 30 mg / kg.
It can be said that the compound is safe even when used as a medicine.

【0036】本発明化合物(1)またはその無毒性塩を
医薬として使用するには、これを製剤化し、通常、経口
投与もしくは点滴を含む注射などの非経口投与すればよ
く、その投与量は、投与形態、被投与者の年齢、体重、
症状などによって異なるが、一般には、成人1日当り
0.1mg〜100mg程度である。
In order to use the compound (1) of the present invention or a non-toxic salt thereof as a medicament, it may be prepared into a pharmaceutical preparation and usually administered orally or parenterally by injection including infusion. Dosage form, age, weight,
In general, the dose is about 0.1 mg to 100 mg per day for an adult, although it varies depending on symptoms and the like.

【0037】上記製剤化のための剤形としては、錠剤、
丸剤、散剤、顆粒剤、カプセル剤、注射剤などが挙げら
れるが、その製造のためには、これら製剤に応じた各種
担体、例えば、錠剤、顆粒剤、カプセル剤などの経口剤
は、澱粉、乳糖、白糖、マンニット、カルボキシメチル
セルロース、コーンスターチ、無機塩類などの賦形剤、
澱粉、デキストリン、アラビアゴム、ゼラチン、ヒドロ
キシプロピルスターチ、メチルセルロース、カルボキシ
メチルセルロースナトリウム、ヒドロキシプロピルセル
ロース、結晶セルロース、エチルセルロース、ポリビニ
ルピロリドン、マクロゴールなどの結合剤、澱粉、ヒド
ロキシプロピルスターチ、カルボキシプロピルセルロー
ス、カルボキシメチルセルロースナトリウム、ヒドロキ
シプロピルセルロースなどの崩壊剤、ラウリル硫酸ナト
リウム、大豆レシチン、蔗糖脂肪酸エステル、ポリソル
ベート80などの界面活性剤、タルク、ロウ、水素添加
植物油、蔗糖脂肪酸エステル、ステアリン酸マグネシウ
ム、ステアリン酸カルシウムなどの滑沢剤、流動性促進
剤、矯味剤、着色剤、香料などを使用することができ
る。
The dosage forms for the above formulation include tablets,
Pills, powders, granules, capsules, injections and the like are mentioned. For the production thereof, various carriers according to these preparations, for example, tablets, granules, oral preparations such as capsules include starch. Excipients such as lactose, sucrose, mannitol, carboxymethylcellulose, corn starch, inorganic salts,
Binders such as starch, dextrin, gum arabic, gelatin, hydroxypropyl starch, methylcellulose, sodium carboxymethylcellulose, hydroxypropylcellulose, crystalline cellulose, ethylcellulose, polyvinylpyrrolidone, macrogol, starch, hydroxypropylstarch, carboxypropylcellulose, carboxymethylcellulose Disintegrants such as sodium and hydroxypropylcellulose; surfactants such as sodium lauryl sulfate, soybean lecithin, sucrose fatty acid ester and polysorbate 80; lubricating agents such as talc, wax, hydrogenated vegetable oil, sucrose fatty acid ester, magnesium stearate and calcium stearate. Lubricants, glidants, flavoring agents, coloring agents, flavors and the like can be used.

【0038】また、本発明化合物(1)またはその無毒
性塩は、懸濁液、エマルジョン剤、シロップ剤、エリキ
シル剤としても使用できる。非経口剤は、希釈剤として
一般に注射用蒸留水、生理食塩水、ブドウ糖水溶液、注
射用植物油、プロピレングリコール、ポリエチレングリ
コールなどを使用することができる。さらに必要に応
じ、殺菌剤、防腐剤、安定剤、等張化剤、無痛化剤など
を加えてもよい。
The compound (1) of the present invention or a non-toxic salt thereof can also be used as a suspension, emulsion, syrup or elixir. As the parenteral agent, distilled water for injection, physiological saline, aqueous glucose solution, vegetable oil for injection, propylene glycol, polyethylene glycol and the like can be generally used as a diluent. If necessary, a bactericide, preservative, stabilizer, tonicity agent, soothing agent and the like may be added.

【0039】[0039]

【発明の効果】本目的化合物(1)またはその無毒性塩
のシグマレセプターへの結合能の測定は以下の方法によ
り行い、その結果は表1に示す通りであった。 (A)文献(Proc.Natl.Acad.Sci.
USA,vol.83,8784〜8788(198
6),E.Weber et al)に記載の方法に準
じて本発明の化合物のシグマレセプターへの結合能を測
定した。
The ability of the target compound (1) or a non-toxic salt thereof to bind to the sigma receptor was measured by the following method. The results are shown in Table 1. (A) Reference (Proc. Natl. Acad. Sci.
USA, vol. 83, 8784-8788 (198
6), E. The binding ability of the compound of the present invention to the sigma receptor was measured according to the method described by Weber et al.

【0040】スプレードーリー(Sprague−Da
wley)系雄性ラット(7週令、チャールスリバー)
を断頭後、速やかに脳を取り出し小脳を除いた全脳を5
0mM Tris/HCl緩衝液(pH8.0、TH緩
衝液)でホモジネート後、700xgで10分間遠心し
た。その上清を48,000xgで15分間遠心し、得
られた沈渣をTH緩衝液に再懸濁して37℃、20分間
インキュベートした。これを48,000xgで15分
間遠心し得られた沈渣をTH緩衝液に懸濁して膜標品と
した。
The spray dolly (Sprague-Da)
wley) male rats (7 weeks old, Charles River)
After decapitation, remove the brain immediately and remove 5
After homogenization with 0 mM Tris / HCl buffer (pH 8.0, TH buffer), the mixture was centrifuged at 700 × g for 10 minutes. The supernatant was centrifuged at 48,000 × g for 15 minutes, and the obtained precipitate was resuspended in TH buffer and incubated at 37 ° C. for 20 minutes. This was centrifuged at 48,000 × g for 15 minutes, and the resulting precipitate was suspended in a TH buffer to prepare a membrane preparation.

【0041】この膜標品(約600μg蛋白量)と〔3
H〕1,3−ジ(2−トリル)グアニジン(DTG,N
ew England Nuclear社製)(最終濃
度3nM)を25℃で60分間反応させ、反応液をワツ
トマンGF/Cフイルターで吸引濾過することにより反
応を停止させ、フイルターに吸着した放射活性シンチ
レーションカウンターで測定し、得られた値を総結合量
とした。また10μMのハロペリドールを加えて同様に
測定したものを非特異的結合量(NB)とした。検体の
結合量を測定するには、ハロペリドールの代わりに適宜
の濃度の検体を加えて同様に測定し、検体における測定
値(DTB)を得た。
The membrane sample (about 600 μg protein) and [ 3
H] 1,3-di (2-tolyl) guanidine (DTG, N
ew England Nuclear) (final concentration: 3 nM) was reacted at 25 ° C. for 60 minutes, the reaction was stopped by suction filtration with a Wattman GF / C filter, and the radioactivity adsorbed on the filter was measured by scintillation. > Measured with a ration counter, and the obtained value was used as the total binding amount. The amount of nonspecific binding (NB) was determined by adding 10 μM of haloperidol and measuring in the same manner. In order to measure the binding amount of the sample, an appropriate concentration of the sample was added in place of haloperidol, and the same measurement was performed to obtain a measured value (DTB) in the sample.

【0042】 (B)Ki値(薬物の受容体に対する親和性)計算法 ある一定濃度における検体の結合阻害率を次の計算法で
算出した。結合阻害率(%)=〔1−(DTB−NB)
÷(TB−NB)〕×100各検体毎に適宜の濃度(高
濃度から低濃度まで)における結合阻害率を求め、横軸
に濃度の対数値、縦軸に結合阻害率をプロットし、非線
形最小二乗法にて曲線を引き、IC50値を求めた。
(B) Calculation Method of Ki Value (Affinity of Drug for Receptor) The binding inhibition rate of a sample at a certain concentration was calculated by the following calculation method. Binding inhibition rate (%) = [1- (DTB-NB)
{(TB-NB)] × 100 The binding inhibition rate at an appropriate concentration (from high concentration to low concentration) was determined for each sample, and the logarithmic value of the concentration was plotted on the horizontal axis, and the binding inhibition rate was plotted on the vertical axis, and the nonlinearity was plotted. A curve was drawn by the least squares method, and an IC50 value was determined.

【0043】Ki値は次の計算式で算出した。 Ki=(IC50)÷〔1+(L)/Kd〕 但し式中、(L)は実験に用いた放射性リガンド濃度
(3nM)、Kdは放射性リガンドの受容体に対する親
和性を表す濃度(10.6nM)、IC50は受容体と
放射性リガンドとの結合を50%阻害する薬物濃度であ
る。シグマレセプターに対する結合能を表1に示す。
The Ki value was calculated by the following equation. Ki = (IC50) ÷ [1+ (L) / Kd] where (L) is the concentration of the radioligand used in the experiment (3 nM), and Kd is the concentration (10.6 nM) representing the affinity of the radioligand for the receptor. ), IC50 is the drug concentration that inhibits the binding between the receptor and the radioligand by 50%. Table 1 shows the binding ability to the sigma receptor.

【0044】[0044]

【表1】 [Table 1]

【0045】前記試験例から明らかなように、本発明
化合物(1)またはその無毒性塩はシグマレセプターに
高い親和性を有し、他のレセプターに対しては殆ど親和
性を示さなかった。
As is apparent from the test examples, the present compound (1) or its non-toxic salts have a high affinity for the sigma receptor, it had little affinity for other receptors.

【0046】次に、本発明の化合物(1)の薬理学的作
用について述べる。 アポモルヒネ誘発クライミングの抑制作用 ドーパミン作動薬であるアポモルヒネをマウスに投与す
ると種々の異常行動が観察され、なかでもケージをよじ
登る行動(クライミング)はヒトでの精神分裂病と密接
な関係があることが知られている。すなわち、ある薬物
がマウスでのアポモルヒネ誘発クライミングの抑制作用
を有していれば、その薬物はヒトにおいて抗精神分裂病
作用を有すると予測することができる。
Next, the pharmacological action of the compound (1) of the present invention will be described. Inhibitory effect of apomorphine-induced climbing When apomorphine, a dopamine agonist, is administered to mice, various abnormal behaviors are observed, and it is known that climbing behavior in the cage (climbing) is closely related to schizophrenia in humans. Have been. That is, if a certain drug has an inhibitory effect on apomorphine-induced climbing in mice, it can be predicted that the drug has an anti-schizophrenic effect in humans.

【0047】ICR系雄性マウス(チャールス・リバ
ー)に本発明化合物を経口投与し、その30分後にアポ
モルヒネ2mg/kgを皮下投与した。アポモルヒネ投
与後20分から23分までの3分間のクライミング行動
を観察した。クライミング行動はステンレススチール製
金網ケージにマウスを入れ、観察時間中にケージの1/
2以上上部へ留まっている時間を測定した。アポモルヒ
ネ単独群のクライミング時間を100%として被験薬物
による時間短縮を抑制率で示した。アポモルヒネ誘発ク
ライミングの抑制作用を表2に示す。
The compound of the present invention was orally administered to male ICR mice (Charles River), and 30 minutes later, 2 mg / kg of apomorphine was subcutaneously administered. Climbing behavior for 3 minutes from 20 to 23 minutes after administration of apomorphine was observed. Climbing was performed by placing the mouse in a stainless steel wire mesh cage.
The time of staying two or more at the top was measured. Assuming that the climbing time of the apomorphine alone group was 100%, the time reduction by the test drug was shown by the inhibition rate. Table 2 shows the inhibitory effect of apomorphine-induced climbing.

【0048】[0048]

【表2】 [Table 2]

【0049】本発明化合物(1)はアポモルヒネ誘発ク
ライミング行動を抑制した。これらの成績より、本発明
化合物(1)は、非常に強い抗精神分裂病作用を有する
ことが認められた。
Compound (1) of the present invention inhibited apomorphine-induced climbing behavior. From these results, it was confirmed that the compound (1) of the present invention has a very strong antischizophrenic effect.

【0050】前記試験例から明らかなように、本発明
化合物(1)またはその無毒性塩はシグマレセプターに
高い親和性を有し、他のレセプターに対しては殆ど親和
性を示さず、また、抗精神分裂病の評価に使用されてい
るアポモルヒネ誘発クライミングの抑制作用に対して有
効性を示したことから、シグマレセプターに関与する疾
病、例えば精神分裂病の治療に有利に使用することがで
きる。
As is apparent from the test examples, the present compound (1) or its non-toxic salts have a high affinity for sigma receptors, hardly exhibit affinity for other receptors, also Effective against the apomorphine-induced climbing that has been used in the evaluation of anti-schizophrenia, and can be advantageously used in the treatment of sigma receptor-related diseases such as schizophrenia .

【0051】[0051]

【実施例】次に、参考例および実施例を挙げ、本発明を
さらに詳しく説明するが、本発明は、これに限定される
ものではない。尚、各参考例および各実施例で得られた
目的物の質量分析(MS)および核磁気共鳴スペクトル
1H−NMR)は表3〜4に示す。
EXAMPLES Next, the present invention will be described in more detail with reference to Reference Examples and Examples, but the present invention is not limited thereto. The mass spectrometry (MS) and nuclear magnetic resonance spectrum of the compound obtained in the Reference Examples and Examples (1 H-NMR) are shown in Table 3-4.

【0052】参考例 1 (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン−2−オン (1S)−樟脳8.31gとヒドロキシルアミン−O−
スルホン酸9.25gを酢酸200ml中7時間加熱還
流した。反応後、減圧濃縮し、得られた残渣をクロロホ
ルム溶液として飽和重曹水で洗浄した。有機層を無水硫
酸ナトリウムで乾燥し、乾燥剤濾別後、濾液を減圧濃縮
した。得られた残渣をシリカゲルカラムクロマトグラフ
イー(ワコーゲル、C200、クロロホルム)で精製
し、表題の目的物を得た。収量5.57g(収率56
%) 〔α〕D 25=+25.0゜(c 1,メタノール)
Reference Example 1 (1S) -1,8,8-trimethyl-3-azabicyclo
[ 3.2.1 ] Octane-2-one (1S) -camphor (8.31 g) and hydroxylamine-O-
9.25 g of sulfonic acid was heated and refluxed in 200 ml of acetic acid for 7 hours. After the reaction, the reaction mixture was concentrated under reduced pressure, and the obtained residue was washed with saturated aqueous sodium hydrogen carbonate as a chloroform solution. The organic layer was dried over anhydrous sodium sulfate, and after filtering off the desiccant, the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (Wako gel, C200, chloroform) to obtain the title compound. 5.57 g (yield 56
%) [Α] D 25 = + 25.0 ° (c 1, methanol)

【0053】参考例 2 (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン 水素化リチウムアルミニウム0.88gのテトラヒドロ
フラン(THF)20ml溶液に(1S)−1,8,8
−トリメチル−3−アザビシクロ[3.2.1]オクタ
ン−2−オン1.93gを加え22時間加熱還流した。
反応後冷却し、6N塩酸続いて5N水酸化ナトリウムを
加え、アルカリ性とした。不溶物を濾別し、濾液をジエ
チルエーテル(エーテル)抽出して無水硫酸ナトリウム
で乾燥し、乾燥剤濾別後、濾液を減圧濃縮し、表題の目
的物を得た。収量1.70g(収率97%) 〔α〕D 25=−17.2°(c 1,メタノール)
Reference Example 2 (1S) -1,8,8-Trimethyl-3-azabicyclo
[ 3.2.1 ] octane (1S) -1,8,8 was added to a solution of 0.88 g of lithium aluminum hydride in 20 ml of tetrahydrofuran (THF).
1.93 g of -trimethyl-3-azabicyclo [3.2.1] octan-2-one was added, and the mixture was refluxed for 22 hours.
After the reaction, the mixture was cooled, and 6N hydrochloric acid and then 5N sodium hydroxide were added to make the mixture alkaline. The insoluble material was separated by filtration, the filtrate was extracted with diethyl ether (ether), dried over anhydrous sodium sulfate, and after filtering the desiccant, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 1.70 g (97% yield) [α] D 25 = -17.2 ° (c 1, methanol)

【0054】実施例 1 (1S)−3−〔2−(1−アダマンチル)エチル〕−
1,8,8−トリメチル−3−アザビシクロ3.2.
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩490mgの塩化メチレ
ン20ml溶液にトリエチルアミン0.43mlを加
え、0℃で1時間攪拌した。そこへ、1−アダマンチル
酢酸552mg、続いて1−エチル−3−(3’−ジメ
チルアミノプロピル)カルボジイミド塩酸塩(WSC)
595mgを加え、徐々に室温に戻し23時間攪拌し
た。反応後、10%水酸化ナトリウムで洗浄し、無水硫
酸ナトリウムで乾燥した。乾燥剤濾別後、濾液を減圧濃
縮して粗(1S)−3−(1−アダマンチルアセチル)
−1,8,8−トリメチル−3−アザビシクロ3.
2.1オクタンを得た。
Example 1 (1S) -3- [2- (1-adamantyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [ 3.2.
1 ] octane (1S) -1,8,8-trimethyl-3-azabicyclo
To a solution of [ 3.2.1 ] octane hydrochloride (490 mg) in methylene chloride (20 ml) was added triethylamine (0.43 ml), and the mixture was stirred at 0 ° C for 1 hour. There, 552 mg of 1-adamantyl acetic acid, followed by 1-ethyl-3- (3′-dimethylaminopropyl) carbodiimide hydrochloride (WSC).
After adding 595 mg, the mixture was gradually returned to room temperature and stirred for 23 hours. After the reaction, it was washed with 10% sodium hydroxide and dried over anhydrous sodium sulfate. After filtration of the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3- (1-adamantylacetyl).
-1,8,8-Trimethyl-3-azabicyclo [ 3.
2.1 ] Octane was obtained.

【0055】これを単離することなく、水素化リチウム
アルミニウム196mgのTHF25ml溶液へ加え、
1時間加熱還流した。反応後、冷却し、エーテル、水そ
して10%水酸化ナトリウム水溶液を加え不溶物を濾別
し、濾液をエーテルで抽出し、無水硫酸ナトリウムで乾
燥した。乾燥剤濾別後、濾液を減圧濃縮して得られた残
渣をフラッシュカラムクロマトグラフイー(メルク、シ
リカゲル60:230−600メッシュ、クロロホル
ム)で精製し、表題の目的物を得た。収量737mg
(収率91%)得られた表題化合物に2倍モル量の塩化
水素メタノール溶液を加え、濃縮してジエチルエーテル
で結晶化し、塩酸塩を得た。 〔α〕D 25=−8.6°(c=0.5、メタノール)
This was added without isolation to a solution of 196 mg of lithium aluminum hydride in 25 ml of THF,
The mixture was refluxed for 1 hour. After the reaction, the reaction mixture was cooled, ether, water and a 10% aqueous sodium hydroxide solution were added thereto, and the insolubles were filtered off. The filtrate was extracted with ether and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure, and the obtained residue was purified by flash column chromatography (Merck, silica gel 60: 230-600 mesh, chloroform) to obtain the title compound. Yield 737mg
A 2-fold molar amount of a methanol solution of hydrogen chloride was added to the obtained title compound, and the mixture was concentrated and crystallized from diethyl ether to obtain a hydrochloride. [Α] D 25 = −8.6 ° (c = 0.5, methanol)

【0056】実施例 2 (1S)−3−〔2−(2−ノルボルニル)エチル〕−
1,8,8−トリメチル−3−アザビシクロ3.2.
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩485mgの塩化メチレ
ン20ml溶液にトリエチルアミン0.43mlを加
え、0℃で40分攪拌した。そこへ、2−ノルボニル酢
酸0.41m1、続いてWSC588mgを加え、徐々
に室温に戻し23時間攪拌した。反応後、減圧濃縮し、
エーテル溶液にして5N水酸化ナトリウムで洗浄後、無
水硫酸ナトリウムで乾燥した。乾燥剤濾別後、濾液を減
圧濃縮して粗(1S)−3−(2−ノルボルニルアセチ
ル)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタンを得た。
Example 2 (1S) -3- [2- (2-norbornyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [ 3.2.
1 ] octane (1S) -1,8,8-trimethyl-3-azabicyclo
To a solution of [ 3.2.1 ] octane hydrochloride (485 mg) in methylene chloride (20 ml) was added triethylamine (0.43 ml), and the mixture was stirred at 0 ° C for 40 minutes. Thereto was added 0.41 ml of 2-norbornylacetic acid, and subsequently 588 mg of WSC, and the mixture was gradually returned to room temperature and stirred for 23 hours. After the reaction, concentration under reduced pressure,
It was made into an ether solution, washed with 5N sodium hydroxide, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3- (2-norbornylacetyl) -1,8,8-trimethyl-3-azabicyclo.
[ 3.2.1 ] Octane was obtained.

【0057】これを単離することなく、水素化リチウム
アルミニウム194mgのTHF20ml溶液へ加え、
1時間加熱還流した。反応後、冷却し、エーテル、水そ
して10%水酸化ナトリウム水溶液を加え不溶物を濾別
し、濾液をエーテルで抽出し、無水硫酸ナトリウムで乾
燥した。乾燥剤濾別後、濾液を減圧濃縮して得られた残
渣をフラッシュカラムクロマトグラフイー(メルク、シ
リカゲル60:230−600メッシュ、クロロホルム
〜クロロホルム:アセトン=20:1)で精製し、表題
の目的物を得た。収量618mg(収率88%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−11.3°(c=0.5、メタノール)
This was added without isolation to a solution of 194 mg of lithium aluminum hydride in 20 ml of THF,
The mixture was refluxed for 1 hour. After the reaction, the reaction mixture was cooled, ether, water and a 10% aqueous sodium hydroxide solution were added thereto, and the insolubles were filtered off. The filtrate was extracted with ether and dried over anhydrous sodium sulfate. After filtering off the drying agent, the residue obtained by concentrating the filtrate under reduced pressure was purified by flash column chromatography (Merck, silica gel 60: 230-600 mesh, chloroform-chloroform: acetone = 20: 1) to obtain the title compound. I got something. Yield: 618 mg (88% yield) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -11.3 ° (c = 0.5, methanol)

【0058】実施例3 (1S)−3−(2−シクロペンチルエチル)−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩0.49gの塩化メチレ
ン20ml溶液にトリエチルアミン0.43mlを加
え、0℃で45分撹拌した。そこへ、シクロペンチル酢
酸0.36ml、続いてWSC0.59gを加え、徐々
に室温に戻し24時間撹拌した。反応液を、10%水酸
化ナトリウムで洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−シクロペンチルアセチル−1,8,8−トリメチル−
3−アザビシクロ3.2.1オクタンを得た。
Example 3 (1S) -3- (2-cyclopentylethyl) -1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
Octane (1S) -1,8,8-trimethyl-3-azabicyclo
[ 3.2.1 ] 0.43 ml of triethylamine was added to a solution of 0.49 g of octane hydrochloride in 20 ml of methylene chloride, and the mixture was stirred at 0 ° C. for 45 minutes. Thereto, 0.36 ml of cyclopentylacetic acid and 0.59 g of WSC were added, and the mixture was gradually returned to room temperature and stirred for 24 hours. The reaction solution was washed with 10% sodium hydroxide and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-Cyclopentylacetyl-1,8,8-trimethyl-
3-Azabicyclo [ 3.2.1 ] octane was obtained.

【0059】これを単離することなく、水素化リチウム
アルミニウム0.19gのTHF30ml溶液へ加え1
時間半加熱還流した。反応液を冷却し、エーテル、水そ
して10%水酸化ナトリウムを加え不溶物を濾別し、濾
液をエーテルで抽出し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して得られた残渣を
フラッシュカラムクロマトグラフィー(メルク、シリカ
ゲル60:230−600メッシュ、クロロホルム〜ク
ロロホルム:アセトン=20:1)で精製し、表題の目
的物を得た。収量0.58g(収率91%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−11.8°(c 0.5,メタノール)
This was added without isolation to a solution of 0.19 g of lithium aluminum hydride in 30 ml of THF.
The mixture was refluxed for half an hour. The reaction solution was cooled, ether, water and 10% sodium hydroxide were added, and the insolubles were filtered off. The filtrate was extracted with ether and dried over anhydrous sodium sulfate. After filtering off the drying agent, the residue obtained by concentrating the filtrate under reduced pressure was purified by flash column chromatography (Merck, silica gel 60: 230-600 mesh, chloroform-chloroform: acetone = 20: 1), and the title compound was obtained. I got Yield: 0.58 g (yield: 91%) Treatment was conducted in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -11.8 ° (c 0.5, methanol)

【0060】実施例4 (1S)−3−(2−シクロヘキシルエチル)−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩0.95gの塩化メチレ
ン20ml溶液にトリエチルアミン0.84mlを加
え、0℃で30分撹拌した。そこへシクロヘキシル酢酸
0.72g、続いてWSC1.35gを加え、徐々に室
温に戻し25時間撹拌した。反応液を、飽和食塩水で洗
浄し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別後、
濾液を減圧濃縮して粗(1S)−3−シクロヘキシルア
セチル−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタンを得た。
Example 4 (1S) -3- (2-cyclohexylethyl) -1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
Octane (1S) -1,8,8-trimethyl-3-azabicyclo
To a solution of [ 3.2.1 ] octane hydrochloride (0.95 g) in methylene chloride (20 ml) was added triethylamine (0.84 ml), and the mixture was stirred at 0 ° C. for 30 minutes. 0.72 g of cyclohexylacetic acid and 1.35 g of WSC were added thereto, and the mixture was gradually returned to room temperature and stirred for 25 hours. The reaction solution was washed with a saturated saline solution and dried over anhydrous sodium sulfate. After filtering the desiccant,
The filtrate was concentrated under reduced pressure to give crude (1S) -3-cyclohexylacetyl-1,8,8-trimethyl-3-azabicyclo.
[ 3.2.1 ] Octane was obtained.

【0061】これを単離することなく、水素化リチウム
アルミニウム0.38gのTHF30ml溶液へ加え1
時間加熱還流した。反応液を冷却し、6N塩酸、続いて
1N水酸化ナトリウムを加え不溶物を濾別し、濾液を減
圧濃縮した。得られた残渣をシリカゲルカラムクロマト
グラフィー(ワコーゲル、C200、クロロホルム:ア
セトン:メタノール=10:1:0.1)で精製し、表
題の目的物を得た。収量1.01g(収率77%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−11.5°(c 0.5,メタノール)
This was added without isolation to a solution of 0.38 g of lithium aluminum hydride in 30 ml of THF.
Heated to reflux for an hour. The reaction solution was cooled, 6N hydrochloric acid and then 1N sodium hydroxide were added, insolubles were filtered off, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (Wakogel, C200, chloroform: acetone: methanol = 10: 1: 0.1) to give the title compound. Yield: 1.01 g (yield: 77%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -11.5 ° (c 0.5, methanol)

【0062】実施例5 (1R)−3−シクロヘキシルアセチル−1,8,8−
トリメチル−3−アザビシクロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩0.95gの塩化メチレ
ン20ml溶液にトリエチルアミン0.84mlを加
え、0℃で30分撹拌した。そこへシクロヘキシル酢酸
0.72g、続いてWSC1.35gを加え、徐々に室
温に戻し24時間撹拌した。反応液を飽和食塩水で洗浄
し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別後、濾
液を減圧濃縮して得られた残渣をシリカゲルカラムクロ
マトグラフィー(ワコーゲル、C200、クロロホル
ム:メタノール=50:1)で精製し、表題の目的物を
得た。収量0.52g(収率37%)
Example 5 (1R) -3-cyclohexylacetyl-1,8,8-
Trimethyl-3-azabicyclo [3.2.1] octane (1R) -1,8,8-trimethyl-3-azabicyclo
To a solution of [ 3.2.1 ] octane hydrochloride (0.95 g) in methylene chloride (20 ml) was added triethylamine (0.84 ml), and the mixture was stirred at 0 ° C. for 30 minutes. 0.72 g of cyclohexylacetic acid and 1.35 g of WSC were added thereto, and the mixture was gradually returned to room temperature and stirred for 24 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure, and the residue obtained was purified by silica gel column chromatography (Wako gel, C200, chloroform: methanol = 50: 1) to obtain the title compound. Yield 0.52 g (37% yield)

【0063】実施例6 (1R)−3−(2−シクロヘキシルエチル)−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン 水素化リチウムアルミニウム0.15gのTHF20m
l溶液へ(1R)−3−シクロヘキシルアセチル−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン0.52gを加え1時間加熱還流した。反応液
を冷却し、水を加え不溶物を濾別し、濾液を減圧濃縮し
た。得られた残渣をシリカゲルカラムクロマトグラフィ
ー(ワコーゲル、C200、クロロホルム:アセトン:
メタノール=5:1:0.1)で精製し、表題の目的物
を得た。収量0.30g(収率61%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+11.6°(c 0.5,メタノール)
Example 6 (1R) -3- (2-cyclohexylethyl) -1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
Octane Lithium aluminum hydride 0.15g THF 20m
1 solution to (1R) -3-cyclohexylacetyl-1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
0.52 g of octane was added, and the mixture was heated under reflux for 1 hour. The reaction solution was cooled, water was added, insolubles were filtered off, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wakogel, C200, chloroform: acetone:
Purification with methanol (5: 1: 0.1) gave the title compound. Yield: 0.30 g (61% yield) Treatment was carried out in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = + 11.6 ° (c 0.5, methanol)

【0064】参考例3 メチルシクロヘプチリデンアセテート シクロヘプタノン1.18mlとメチルジエチルホスホ
ノアセテート2.21mlをベンゼン10mlに溶解
し、水素化ナトリウム(60%、油分散体)0.08g
を加え、室温で15時間、その後、6時間加熱還流し
た。反応液に水を加え、クロロホルムで抽出し、無水硫
酸ナトリウムで乾燥した。乾燥剤濾別後、濾液を減圧濃
縮した。得られた残渣をシリカゲルカラムクロマトグラ
フィー(ワコーゲル、C200、クロロホルム)で精製
し、表題の目的物を得た。収量1.20g(収率71
%)
Reference Example 3 Methylcycloheptylidene acetate 1.18 ml of cycloheptanone and 2.21 ml of methyl diethylphosphonoacetate were dissolved in 10 ml of benzene, and 0.08 g of sodium hydride (60%, oil dispersion) was dissolved.
Was added, and the mixture was heated and refluxed at room temperature for 15 hours and then for 6 hours. Water was added to the reaction solution, extracted with chloroform, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (Wako gel, C200, chloroform) to obtain the title compound. Yield 1.20 g (yield 71
%)

【0065】参考例4 シクロヘプチルエチルアルコール 水素化リチウムアルミニウム0.81gのTHF35m
l溶液にメチルシクロヘプチリデンアセテート1.20
gを加え4時間加熱還流した。反応液を冷却し、水と1
0%水酸化ナトリウムを加え不溶物を濾別した。濾液を
エーテルで抽出し、無水硫酸ナトリウムで乾燥した。乾
燥剤濾別後、濾液を減圧濃縮した。これをメタノール5
0mlに溶解し、10%Pd−C0.12gを加え水素
気流下、常温常圧にて4時間接触還元を行った。反応
後、Pd−Cを濾別し、濾液を減圧濃縮して表題の目的
物を得た。収量0.45g(収率45%)
Reference Example 4 Cycloheptylethyl alcohol Lithium aluminum hydride 0.81 g of THF 35 m
1 solution of methylcycloheptylidene acetate 1.20
g was added and heated under reflux for 4 hours. Cool the reaction and add 1
0% sodium hydroxide was added and the insolubles were filtered off. The filtrate was extracted with ether and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure. This is methanol 5
The mixture was dissolved in 0 ml, and 0.12 g of 10% Pd-C was added thereto, followed by catalytic reduction at room temperature and normal pressure for 4 hours under a hydrogen stream. After the reaction, Pd-C was separated by filtration, and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 0.45 g (Yield 45%)

【0066】実施例7 (1S)−3−(2−シクロヘプチルエチル)−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン シクロヘプチルエチルアルコール0.45gを塩化メチ
レン20mlに溶解し、0℃に冷却してメタンスルホニ
ルクロライド0.30ml、続いてトリエチルアミン
0.62mlを加え、徐々に室温に戻し22時間半撹拌
した。
Example 7 (1S) -3- (2-Cycloheptylethyl) -1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
Octane cycloheptylethyl alcohol (0.45 g) was dissolved in methylene chloride (20 ml), cooled to 0 ° C., added with methanesulfonyl chloride (0.30 ml), and then triethylamine (0.62 ml).

【0067】反応液を減圧濃縮し、粗メシル体を得た。
これに(1S)−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン塩酸塩0.51gと炭酸
カリウム1.10gを加え、アセトニトリル20ml溶
液として24時間加熱還流した。反応液から不溶物を濾
別し、濾液を減圧濃縮した。得られた残渣をフラッシュ
カラムクロマトグラフィー(メルク、シリカゲル60:
230−600メッシュ、クロロホルム)で精製し、表
題の目的物を得た。収量0.61g(収率82%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−11.7°(c 0.5,メタノール)
The reaction solution was concentrated under reduced pressure to obtain a crude mesyl compound.
0.51 g of (1S) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 1.10 g of potassium carbonate were added thereto, and the mixture was heated under reflux for 24 hours as a 20 ml solution of acetonitrile. The insolubles were separated from the reaction solution by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to flash column chromatography (Merck, silica gel 60:
Purification with 230-600 mesh, chloroform) gave the title compound. Yield: 0.61 g (yield: 82%) Treatment was conducted in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -11.7 ° (c 0.5, methanol)

【0068】参考例5 メチルシクロオクチリデンアセテート シクロオクタノン2.00gとメチルジエチルホスホノ
アセテート3.50mlをTHF20mlに溶解し、0
℃に冷却してカリウムターシャリブトキシド2.67g
のターシャリーブタノール10ml溶液を20分かけて
滴下した。徐々に室温に戻し12時間撹拌した。反応液
に水を加え、THFのみを減圧濃縮した。得られた残渣
を酢酸エチルで抽出し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮した。得られた残渣
をシリカゲルカラムクロマトグラフィー(ワコーゲル、
C200、クロロホルム)で精製し、表題の目的物を得
た。収量1.33g(収率46%)
Reference Example 5 Methylcyclooctylidene acetate 2.00 g of cyclooctanone and 3.50 ml of methyl diethylphosphonoacetate were dissolved in 20 ml of THF.
2.67 g of potassium tertiary butoxide
Was added dropwise over 20 minutes. The mixture was gradually returned to room temperature and stirred for 12 hours. Water was added to the reaction solution, and only THF was concentrated under reduced pressure. The obtained residue was extracted with ethyl acetate and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wakogel,
(C200, chloroform) to give the title compound. 1.33 g (46% yield)

【0069】参考例6 シクロオクチル酢酸メチルエステル メチルシクロオクチリデンアセテート0.50gをメタ
ノール5mlに溶解し、10%Pd−C0.10gを加
え水素気流下、常温常圧にて3時間接触還元を行った。
反応後、Pd−Cを濾別し、濾液を減圧濃縮して表題の
目的物を得た。収量0.45g(収率88%)
Reference Example 6 Cyclooctyl acetic acid methyl ester 0.50 g of methyl cyclooctylidene acetate was dissolved in 5 ml of methanol, 0.10 g of 10% Pd-C was added, and catalytic reduction was carried out for 3 hours at room temperature and normal pressure under a hydrogen stream. Was.
After the reaction, Pd-C was separated by filtration, and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 0.45 g (88% yield)

【0070】参考例7 シクロオクチル酢酸 シクロオクチル酢酸メチルエステル0.45gをメタノ
ール10mlに溶解し、そこへ、1N水酸化ナトリウム
4.0mlを加え室温で7時間撹拌した。反応液を減圧
濃縮し、残渣に飽和重曹水を加えエーテルで洗浄した。
水層を冷却し、6N塩酸で酸性とした後、酢酸エチルで
抽出し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別
後、濾液を減圧濃縮して表題の目的物を得た。収量0.
28g(収率67%)
Reference Example 7 Cyclooctylacetic acid 0.45 g of cyclooctylacetic acid methyl ester was dissolved in 10 ml of methanol, and 4.0 ml of 1N sodium hydroxide was added thereto, followed by stirring at room temperature for 7 hours. The reaction solution was concentrated under reduced pressure, saturated aqueous sodium hydrogen carbonate was added to the residue, and the mixture was washed with ether.
The aqueous layer was cooled, acidified with 6N hydrochloric acid, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 0.
28 g (67% yield)

【0071】実施例8 (1S)−3−(2−シクロオクチルエチル)−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩0.28gの塩化メチレ
ン10ml溶液にトリエチルアミン0.24mlを加
え、0℃で30分撹拌した。そこへシクロオクチル酢酸
0.25g、続いてWSC0.40gを加え、徐々に室
温に戻し21時間撹拌した。反応液を飽和食塩水で洗浄
し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別後、濾
液を減圧濃縮して粗(1S)−3−シクロオクチルアセ
チル−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタンを得た。
Example 8 (1S) -3- (2-Cyclooctylethyl) -1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
Octane (1S) -1,8,8-trimethyl-3-azabicyclo
To a solution of 0.28 g of [ 3.2.1 ] octane hydrochloride in 10 ml of methylene chloride was added 0.24 ml of triethylamine, and the mixture was stirred at 0 ° C. for 30 minutes. Thereto was added 0.25 g of cyclooctylacetic acid, followed by 0.40 g of WSC, and the mixture was gradually returned to room temperature and stirred for 21 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain crude (1S) -3-cyclooctylacetyl-1,8,8-trimethyl-3-azabicyclo [3.2.1] octane.

【0072】これを単離することなく、水素化リチウム
アルミニウム0.12gのTHF15ml溶液へ加え1
時間加熱還流した。反応液を冷却し、水を加え不溶物を
濾別し、濾液を減圧濃縮した。得られた残渣をシリカゲ
ルカラムクロマトグラフィー(ワコーゲル、C200、
クロロホルム:アセトン=10:1)で精製し、表題の
目的物を得た。収量0.26g(収率61%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−12.9°(c 0.5,メタノール)
This was added without isolation to a solution of 0.12 g of lithium aluminum hydride in 15 ml of THF.
Heated to reflux for an hour. The reaction solution was cooled, water was added, insolubles were filtered off, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wakogel, C200,
Purification with chloroform: acetone = 10: 1) gave the title compound. Yield: 0.26 g (61% yield) Treatment was conducted in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -12.9 ° (c 0.5, methanol)

【0073】実施例9 (1S)−3−(4−シクロヘキシル−1−ブチル)−
1,8,8−トリメチル−3−アザビシクロ3.2.
オクタン 4−シクロヘキシル−1−ブタノール0.52mlを塩
化メチレン20mlに溶解し、0℃に冷却してメタンス
ルホニルクロライド0.28ml、続いてトリエチルア
ミン0.50mlを加え、徐々に室温に戻し6時間半撹
拌した。反応液を減圧濃縮し、粗メシル体を得た。
Example 9 (1S) -3- (4-Cyclohexyl-1-butyl)-
1,8,8-Trimethyl-3-azabicyclo [ 3.2.
1 ] Octane 4-cyclohexyl-1-butanol (0.52 ml) was dissolved in methylene chloride (20 ml), cooled to 0 ° C., added with methanesulfonyl chloride (0.28 ml), and then triethylamine (0.50 ml). Half agitated. The reaction solution was concentrated under reduced pressure to obtain a crude mesyl form.

【0074】これに(1S)−1,8,8−トリメチル
−3−アザビシクロ3.2.1オクタン塩酸塩0.
47gと炭酸カリウム1.04gを加え、アセトニトリ
ル20ml溶液として15時間加熱還流した。反応液か
ら不溶物を濾別し、濾液を減圧濃縮した。得られた残渣
をフラッシュカラムクロマトグラフィー(メルク、シリ
カゲル60:230−600メッシュ、クロロホルム)
で精製し、表題の目的物を得た。収量0.55g(収率
75%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−13.1°(c 0.5,メタノール)
To this was added (1S) -1,8,8-trimethyl-3-azabicyclo [ 3.2.1 ] octane hydrochloride.
47 g and potassium carbonate (1.04 g) were added, and the mixture was heated under reflux for 15 hours as a 20 ml solution of acetonitrile. The insolubles were separated from the reaction solution by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to flash column chromatography (Merck, silica gel 60: 230-600 mesh, chloroform).
And the title compound was obtained. Yield 0.55 g (yield 75%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -13.1 ° (c 0.5, methanol)

【0075】実施例10 (1S)−3−(3−シクロヘキシルプロピル)−1,
8,8−トリメチル−3−アザビシクロ3.2.1
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩0.49gの塩化メチレ
ン20ml溶液にトリエチルアミン0.43mlを加
え、0℃で40分撹拌した。そこへ3−シクロヘキシ
ルプロピオン酸0.44ml、続いてWSC0.59g
を加え、徐々に室温に戻し45時間撹拌した。反応液を
減圧濃縮し、残渣をエーテル溶液にして10%水酸化ナ
トリウムで洗浄後、無水硫酸ナトリウムで乾燥した。乾
燥剤濾別後、濾液を減圧濃縮して粗(1S)−3−(3
−シクロヘキシルプロピオニル)−1,8,8−トリメ
チル−3−アザビシクロ[3.2.1]オクタンを得
た。
Example 10 (1S) -3- (3-Cyclohexylpropyl) -1,
8,8-Trimethyl-3-azabicyclo [ 3.2.1 ]
Octane (1S) -1,8,8-trimethyl-3-azabicyclo
[ 3.2.1 ] 0.43 ml of triethylamine was added to a solution of 0.49 g of octane hydrochloride in 20 ml of methylene chloride, and the mixture was stirred at 0 ° C. for 40 minutes. Thereto, 3-cyclohexyl propionic acid 0.44 ml, followed by WSC0.59g
, And the mixture was gradually returned to room temperature and stirred for 45 hours. The reaction solution was concentrated under reduced pressure, the residue was converted to an ether solution, washed with 10% sodium hydroxide, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3- (3
-Cyclohexylpropionyl) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane was obtained.

【0076】これを単離することなく、水素化リチウム
アルミニウム0.19gのTHF20ml溶液へ加え1
時間半加熱還流した。反応液を冷却し、エーテル、水そ
して10%水酸化ナトリウムを加え不溶物を濾別した。
濾液をエーテルで抽出し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮した。得られた残渣
をフラッシュカラムクロマトグラフィー(メルク、シリ
カゲル60:230−600メッシュ、クロロホルム〜
クロロホルム:アセトン=20:1)で精製し、表題の
目的物を得た。収量0.56g(収率79%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−11.3°(c 0.5,メタノール)
This was added without isolation to a solution of 0.19 g of lithium aluminum hydride in 20 ml of THF.
The mixture was refluxed for half an hour. The reaction solution was cooled, ether, water and 10% sodium hydroxide were added, and the insolubles were filtered off.
The filtrate was extracted with ether and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure. The obtained residue was subjected to flash column chromatography (Merck, silica gel 60: 230-600 mesh, chloroform-
Purification with chloroform: acetone = 20: 1) gave the title compound. Yield: 0.56 g (79% yield) Treatment was conducted in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = 11.3 ° (c 0.5, methanol)

【0077】実施例11 (1S)−3−シクロヘキシルメチル−1,8,8−ト
リメチル−3−アザビシクロ3.2.1オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン塩酸塩0.50gとシクロヘキ
シルメチルブロマイド0.44mlをアセトニトリル2
5mlに溶解し、これに炭酸カリウム1.10gを加え
26時間加熱還流した。反応液から不溶物を濾別し、濾
液を減圧濃縮した。得られた残渣をフラッシュカラムク
ロマトグラフィー(メルク、シリカゲル60:230−
600メッシュ、クロロホルム〜クロロホルム:アセト
ン=20:1)で精製し、表題の目的物を得た。収量
0.66g(収率100%)実施例1と同様の方法で処
理し、塩酸塩を得た。 〔α〕D 25=−11.0°(c 0.5,メタノール)
Example 11 (1S) -3-cyclohexylmethyl-1,8,8-trimethyl-3-azabicyclo [ 3.2.1 ] octane (1S) -1,8,8-trimethyl-3-azabicyclo
[ 3.2.1 ] Octane hydrochloride (0.50 g) and cyclohexylmethyl bromide (0.44 ml) were mixed with acetonitrile 2
The mixture was dissolved in 5 ml, and potassium carbonate (1.10 g) was added thereto, followed by heating under reflux for 26 hours. The insolubles were separated from the reaction solution by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to flash column chromatography (Merck, silica gel 60: 230-
Purification was performed using 600 mesh, chloroform-chloroform: acetone = 20: 1) to obtain the title compound. Yield: 0.66 g (100% yield) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -11.0 ° (c 0.5, methanol)

【0078】実施例12 (1R)−3−シクロヘキシルメチル−1,8,8−ト
リメチル−3−アザビシクロ3.2.1オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
3.2.1オクタン3.00gとシクロヘキシルメ
チルブロマイド5.48mlをアセトニトリル50ml
に溶解し、これに炭酸カリウム6.78gを加え39時
間加熱還流した。反応液から不溶物を濾別し、濾液を減
圧濃縮した。得られた残渣をシリカゲルカラムクロマト
グラフィー(ワコーゲル、C200、クロロホルム)で
精製し、表題の目的物を得た。収量4.62g(収率9
5%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+13.0°(c 0.5,メタノール).
Example 12 (1R) -3-cyclohexylmethyl-1,8,8-trimethyl-3-azabicyclo [ 3.2.1 ] octane (1R) -1,8,8-trimethyl-3-azabicyclo
[ 3.2.1 ] 3.00 g of octane and 5.48 ml of cyclohexylmethyl bromide were added to 50 ml of acetonitrile.
, And 6.78 g of potassium carbonate was added thereto, followed by heating under reflux for 39 hours. The insolubles were separated from the reaction solution by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (Wako gel, C200, chloroform) to obtain the title compound. 4.62 g (yield 9)
5%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = + 13.0 ° (c 0.5, methanol).

【0079】実施例13 (1S)−3−シクロヘキシル−1,8,8−トリメチ
ル−3−アザビシクロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.12gとシクロヘキ
シルブロマイド0.092mlをアセトニトリル5ml
に溶解し、これに炭酸カリウム0.26gを加え51時
間加熱還流した。反応液から不溶物を濾別し、濾液を減
圧濃縮した。得られた残渣をフラッシュカラムクロマト
グラフィー(メルク、シリカゲル60:230−600
メッシュ、クロロホルム〜クロロホルム:アセトン=2
0:1)で精製し、表題の目的物を得た。収量32.0
mg(収率22%) 実施例1と同様の方法で処理し、塩酸塩を得た。
Example 13 (1S) -3-cyclohexyl-1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1S) -1,8,8-trimethyl-3-azabicyclo [3 2.2.1] Octane hydrochloride 0.12 g and cyclohexyl bromide 0.092 ml were mixed with acetonitrile 5 ml
And 0.26 g of potassium carbonate was added thereto, followed by heating under reflux for 51 hours. The insolubles were separated from the reaction solution by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to flash column chromatography (Merck, silica gel 60: 230-600).
Mesh, chloroform to chloroform: acetone = 2
0: 1) to give the title compound. Yield 32.0
mg (yield: 22%) The same treatment as in Example 1 was carried out to obtain a hydrochloride.

【0080】実施例14 (1R)−3−[2−(1−アダマンチル)エチル]−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.95g(5.0ミリ
モル)と1ーアダマンチル酢酸1.17g(6.0ミリ
モル)から実施例1の化合物の合成と同様に反応し、シ
リカゲルカラムクロマトグラフィー(ワコ−ゲル、C2
00、クロロホルム:アセトン=20:1)で精製し、
表題の目的物を得た。収量1.21g(収率77%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+9.2°(c 0.5,メタノール).
Example 14 (1R) -3- [2- (1-adamantyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] Octane (1R) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride 0.95 g (5.0 mmol) and 1-adamantyl acetic acid 1.17 g (6.0 mmol) In the same manner as in the synthesis of the compound of Example 1 and silica gel column chromatography (Wako-gel, C2
00, chloroform: acetone = 20: 1),
The title product was obtained. Yield: 1.21 g (yield: 77%) Treatment was carried out in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = + 9.2 ° (c 0.5, methanol).

【0081】参考例8 メチル 2−アダマンチリデンアセテ−ト 2−アダマンタノン115.00g(0.77モル)と
メチルジエチルホスホノアセテ−ト210.78ml
(1.15モル)のメタノ−ル500ml溶液を0℃に
冷却し、ナトリウムメチラ−トの28%メタノ−ル溶液
371.7gを滴下して徐々に室温に戻し4時間撹拌し
た。反応液を減圧濃縮し、得られた残渣に水を加え酢酸
エチルで抽出した後、無水硫酸ナトリウムで乾燥した。
乾燥剤濾別後、濾液を減圧濃縮して得られた残渣をシリ
カゲルカラムクロマトグラフィー(ワコ−ゲル、C20
0、ノルマルヘキサン:酢酸エチル=20:1)で精製
し、表題の目的物を得た。収量157.70g(収率1
00%)
Reference Example 8 Methyl 2-adamantylidene acetate 115.00 g (0.77 mol) of 2-adamantanone and 210.78 ml of methyl diethylphosphonoacetate
A solution (1.15 mol) of methanol in 500 ml was cooled to 0 ° C., 371.7 g of a 28% methanol solution of sodium methylate was added dropwise, and the mixture was gradually returned to room temperature and stirred for 4 hours. The reaction solution was concentrated under reduced pressure, water was added to the obtained residue, extracted with ethyl acetate, and dried over anhydrous sodium sulfate.
After filtering off the drying agent, the filtrate was concentrated under reduced pressure, and the residue obtained was subjected to silica gel column chromatography (Wako-gel, C20
0, normal hexane: ethyl acetate = 20: 1) to obtain the title compound. Yield 157.70 g (Yield 1
00%)

【0082】参考例9 2−アダマンチル酢酸メチルエステル メチル 2−アダマンチリデンアセテ−ト145g
(0.74モル)のメタノ−ル1150ml溶液に10
%パラジウム炭素2.90gと蟻酸アンモニウム178
g(2.8モル)を加え室温で3時間撹拌した。反応液
からパラジウム炭素を濾別し、濾液を減圧濃縮した。得
られた残渣に水を加え酢酸エチルで抽出した後、無水硫
酸ナトリウムで乾燥した。乾燥剤濾別後、濾液を減圧濃
縮し、表題の目的物を得た。収量146.41g(収率
100%)
Reference Example 9 2-adamantyl acetic acid methyl ester methyl 2-adamantylidene acetate 145 g
(0.74 mol) in 1150 ml of methanol
% Palladium on carbon 2.90 g and ammonium formate 178
g (2.8 mol) was added and the mixture was stirred at room temperature for 3 hours. Palladium carbon was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure. Water was added to the obtained residue, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 146.41 g (100% yield)

【0083】参考例10 2−アダマンチル酢酸 2−アダマンチル酢酸メチルエステル150g(0.7
2モル)のメタノ−ル1125ml溶液に2.5N水酸
化ナトリウム433mlを加え室温で6時間撹拌した。
反応液を減圧濃縮し、残渣に重曹水を加えエ−テルで洗
浄した。水層を12N塩酸を加えpH1にし、酢酸エチ
ルで抽出した後、無水硫酸ナトリウムで乾燥した。乾燥
剤濾別後、濾液を減圧濃縮し、表題の目的物を得た。収
量129.39g(収率93%)
Reference Example 10 2-adamantyl acetic acid 2-adamantyl acetic acid methyl ester 150 g (0.7 g)
433 ml of 2.5 N sodium hydroxide was added to a solution of 2 mol) in methanol (1125 ml), and the mixture was stirred at room temperature for 6 hours.
The reaction solution was concentrated under reduced pressure, aqueous sodium bicarbonate was added to the residue, and the mixture was washed with ether. The aqueous layer was adjusted to pH 1 with 12N hydrochloric acid, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield: 129.39 g (93% yield)

【0084】実施例15 (1S)−3−[2−(2−アダマンチル)エチル]−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.78g(4.1ミリ
モル)の塩化メチレン20ml溶液にトリエチルアミン
0.69ml(5.0ミリモル)を加え、0℃で30分
撹拌した。そこへ、2−アダマンチル酢酸0.80g
(4.1ミリモル)、続いてWSC1.11g(5.7
9ミリモル)を加え、徐々に室温に戻し23時間撹拌し
た。反応液を、飽和食塩水で洗浄し、無水硫酸ナトリウ
ムで乾燥した。乾燥剤濾別後、濾液を減圧濃縮して粗
(1S)−3−(2−アダマンチルアセチル)−1,
8,8−トリメチル−3−アザビシクロ[3.2.1]
オクタンを得た。
Example 15 (1S) -3- [2- (2-adamantyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] Octane (1S) -1,8,8-Trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (0.78 g, 4.1 mmol) in methylene chloride (20 ml) was treated with 0.69 ml (5. (0 mmol) and stirred at 0 ° C. for 30 minutes. There, 0.80 g of 2-adamantyl acetic acid
(4.1 mmol), followed by 1.11 g of WSC (5.7
9 mmol), and the mixture was gradually returned to room temperature and stirred for 23 hours. The reaction solution was washed with a saturated saline solution and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3- (2-adamantylacetyl) -1,
8,8-Trimethyl-3-azabicyclo [3.2.1]
Octane obtained.

【0085】これを単離することなく、水素化リチウム
アルミニウム0.47g(12ミリモル)のTHF50
ml溶液へ加え2時間加熱還流した。反応液を冷却し、
水を加え不溶物を濾別し、濾液を減圧濃縮した。得られ
た残渣をシリカゲルカラムクロマトグラフィー(ワコ−
ゲル、C200、クロロホルム:アセトン=10:1〜
5:1)で精製し、表題の目的物を得た。収量1.26
g(収率97%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−10.2°(c 0.5,メタノール)
Without isolation, 0.47 g (12 mmol) of lithium aluminum hydride in THF 50
The mixture was added to the resulting solution and heated under reflux for 2 hours. Cool the reaction solution,
Water was added, insolubles were removed by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wako-
Gel, C200, chloroform: acetone = 10: 1 to 1
5: 1) to give the title compound. 1.26 yield
g (yield 97%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -10.2 ° (c 0.5, methanol)

【0086】実施例16 (1R)−3−[2−(2−アダマンチル)エチル]−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタン(1R)−1,8,8−トリメチル−3−
アザビシクロ[3.2.1]オクタン塩酸塩0.38g
(2.0ミリモル)と2ーアダマンチル酢酸0.43g
(2.2ミリモル)から実施例15の化合物の合成と同
様に反応し、シリカゲルカラムクロマトグラフィ−(ワ
コ−ゲル、C200、クロロホルム:アセトン=10:
1)で精製し、表題の目的物を得た。収量0.57g
(収率91%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+10.5°(c 0.5,メタノール)
Example 16 (1R) -3- [2- (2-adamantyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] Octane (1R) -1,8,8-trimethyl-3-
0.38 g of azabicyclo [3.2.1] octane hydrochloride
(2.0 mmol) and 0.43 g of 2-adamantyl acetic acid
(2.2 mmol), and reacted in the same manner as in the synthesis of the compound of Example 15; silica gel column chromatography (Wako-gel, C200, chloroform: acetone = 10:
Purification in 1) gave the title compound. Yield 0.57g
(Yield: 91%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = + 10.5 ° (c 0.5, methanol)

【0087】参考例11 2−アダマンチルエタノ−ル 水素化リチウムアルミニウム0.16g(4.2ミリモ
ル)のジエチルエ−テル20ml溶液に2−アダマンチ
ル酢酸メチルエステル0.57g(2.7ミリモル)を
加え2時間加熱還流した。反応液を冷却し、水を加え不
溶物を濾別した。濾液をエ−テル抽出し、無水硫酸ナト
リウムで乾燥した。乾燥剤濾別後、濾液を減圧濃縮し、
表題の目的物を得た。収量0.23g(収率47%)
Reference Example 11 2-adamantylethanol To a solution of lithium aluminum hydride (0.16 g, 4.2 mmol) in diethyl ether (20 ml) was added 2-adamantylacetic acid methyl ester (0.57 g, 2.7 mmol). Heated to reflux for an hour. The reaction solution was cooled, water was added, and insolubles were removed by filtration. The filtrate was extracted with ether and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure,
The title product was obtained. Yield 0.23 g (47% yield)

【0088】実施例17 (1S)−3−[2−(2−アダマンチル)エチル]−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタン 2−アダマンチルエタノ−ル0.64g(3.6ミリモ
ル)の塩化メチレン10ml溶液を0℃に冷却し、メタ
ンスルホニルクロライド0.42ml(5.4ミリモ
ル)続いてトリエチルアミン1.00ml(7.17ミ
リモル)を加え徐々に室温に戻し15時間撹拌した。反
応液を減圧濃縮し、粗メシル体を得た。
Example 17 (1S) -3- [2- (2-adamantyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] A solution of 0.64 g (3.6 mmol) of octane 2-adamantyl ethanol in 10 ml of methylene chloride was cooled to 0 ° C., and 0.42 ml (5.4 mmol) of methanesulfonyl chloride was added, followed by 1.00 ml of triethylamine (7 ml). .17 mmol) and gradually returned to room temperature and stirred for 15 hours. The reaction solution was concentrated under reduced pressure to obtain a crude mesyl form.

【0089】これに(1S)−1,8,8−トリメチル
−3−アザビシクロ[3.2.1]オクタン塩酸塩0.
68g(3.6ミリモル)と炭酸カリウム1.49g
(10.8ミリモル)を加え、アセトニトリル30ml
溶液とし、18時間加熱還流した。反応液の不溶物を濾
別し、濾液を減圧濃縮した。得られた残渣をシリカゲル
カラムクロマトグラフィー(ワコ−ゲル、C200、ク
ロロホルム:アセトン=20:1〜5:1)で精製し、
表題の目的物を得た。収量0.59g(収率53%) 実施例1と同様の方法で処理し、塩酸塩を得た。
To this was added ( 1S) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride.
68 g (3.6 mmol) and potassium carbonate 1.49 g
(10.8 mmol) and 30 ml of acetonitrile
It was made into a solution and heated under reflux for 18 hours. The insoluble matter of the reaction solution was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (Wako-gel, C200, chloroform: acetone = 20: 1 to 5: 1),
The title product was obtained. Yield: 0.59 g (53% yield) The same treatment as in Example 1 was carried out to obtain a hydrochloride.

【0090】実施例18 (1S)−3−[2−(4−メチルシクロヘキシル)エ
チル]−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.95gの塩化メチレ
ン20ml溶液にトリエチルアミン0.84mlを加え
0℃で30分攪拌した。そこへ、4−メチルシクロヘキ
シル酢酸0.94g、続いてWSC1.35gを加え、
徐々に室温に戻し24時間攪拌した。反応後、飽和食塩
水で洗浄し、無水硫酸ナトリウムで乾燥した。乾燥剤濾
別後、濾液を減圧濃縮して粗(1S)−3−(4−メチ
ルシクロヘキシルアセチル)−1,8,8−トリメチル
−3−アザビシクロ[3.2.1]オクタンを得た。
Example 18 (1S) -3- [2- (4-Methylcyclohexyl) ethyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1S) -1,8 To a solution of 0.95 g of 8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 20 ml of methylene chloride was added 0.84 ml of triethylamine, followed by stirring at 0 ° C for 30 minutes. There, 0.94 g of 4-methylcyclohexyl acetic acid and subsequently 1.35 g of WSC were added,
The mixture was gradually returned to room temperature and stirred for 24 hours. After the reaction, the reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain crude (1S) -3- (4-methylcyclohexylacetyl) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane.

【0091】これを単離することなく、水素化リチウム
アルミニウム0.39gのTHF30ml溶液へ加え1
時間加熱還流した。反応後、冷却し、水を加え不溶物を
濾別し、濾液を減圧濃縮した。得られた残渣をシリカゲ
ルカラムクロマトグラフィ−(ワコ−ゲル、C200、
クロロホルム:アセトン=10:1)で精製し、表題の
目的物を得た。収量1.37g(収率100%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−11.0゜(c 0.5、メタノール)
This was added without isolation to a solution of 0.39 g of lithium aluminum hydride in 30 ml of THF.
Heated to reflux for an hour. After the reaction, the reaction mixture was cooled, water was added, insolubles were removed by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (Wako-gel, C200,
Purification with chloroform: acetone = 10: 1) gave the title compound. Yield: 1.37 g (100% yield) The same treatment as in Example 1 was performed to obtain a hydrochloride. [Α] D 25 = -11.0 ゜ (c 0.5, methanol)

【0092】実施例19 (1S)−3−[2−(3−メチル−1−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.51gの塩化メチレ
ン15ml溶液にトリエチルアミン0.53mlを加え
0℃で30分攪拌した。そこへ、3−メチル−1−アダ
マンチル酢酸0.68g、続いてWSC0.73gを加
え、徐々に室温に戻し23.5時間攪拌した。反応後、
飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。
乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3−
(3−メチル−1−アダマンチルアセチル)−1,8,
8−トリメチル−3−アザビシクロ[3.2.1]オク
タンを得た。
Example 19 (1S) -3- [2- (3-Methyl-1-adamantyl) ethyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1S)- 0.53 ml of triethylamine was added to a solution of 0.51 g of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 15 ml of methylene chloride, and the mixture was stirred at 0 ° C. for 30 minutes. Thereto, 0.68 g of 3-methyl-1-adamantylacetic acid and subsequently 0.73 g of WSC were added, and the mixture was gradually returned to room temperature and stirred for 23.5 hours. After the reaction,
The extract was washed with saturated saline and dried over anhydrous sodium sulfate.
After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3-.
(3-methyl-1-adamantylacetyl) -1,8,
8-Trimethyl-3-azabicyclo [3.2.1] octane was obtained.

【0093】これを単離することなく、水素化リチウム
アルミニウム0.21gのTHF15ml溶液へ加え3
時間加熱還流した。反応後、冷却し、水を加え不溶物を
濾別し、濾液を減圧濃縮した。得られた残渣をフラッシ
ュカラムクロマトグラフィ−(メルク、シリカゲル6
0:230−600メッシュ、クロロホルム)で精製
し、表題の目的物を得た。収量0.63g(収率71
%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−9.4゜(c 0.5、メタノール)
This was added without isolation to a solution of 0.21 g of lithium aluminum hydride in 15 ml of THF.
Heated to reflux for an hour. After the reaction, the reaction mixture was cooled, water was added, insolubles were removed by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to flash column chromatography (Merck, silica gel 6).
0: 230-600 mesh, chloroform) to give the title compound. Yield 0.63 g (yield 71
%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -9.4 ゜ (c 0.5, methanol)

【0094】実施例20 (1S)−3−(3−ノルアダマンチルメチル)−1,
8,8−トリメチル−3−アザビシクロ[3.2.1]
オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩100mgの塩化メチレ
ン5ml溶液にトリエチルアミン0.096mlを加え
0℃で30分攪拌した。そこへ、WSC0.132g、
続いて3−ノルアダマンタンカルボン酸96.5mgを
加え、徐々に室温に戻し15.5時間攪拌した。反応液
を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−(3−ノルアダマンチルカルボニル)−1,8,8−
トリメチル−3−アザビシクロ[3.2.1]オクタン
を得た。
Example 20 (1S) -3- (3-Noradamantylmethyl) -1,
8,8-Trimethyl-3-azabicyclo [3.2.1]
Octane (1S) -1,8,8-trimethyl-3-azabicyclo [3.2.1] 0.096 ml of triethylamine was added to a solution of 100 mg of octane hydrochloride in 5 ml of methylene chloride, and the mixture was stirred at 0 ° C. for 30 minutes. There, WSC 0.132g,
Subsequently, 96.5 mg of 3-noradamantanecarboxylic acid was added, and the mixture was gradually returned to room temperature and stirred for 15.5 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-(3-noradamantylcarbonyl) -1,8,8-
Trimethyl-3-azabicyclo [3.2.1] octane was obtained.

【0095】これを単離することなく、水素化リチウム
アルミニウム24.0mgのTHF10ml溶液へ加え
1.5時間加熱還流した。反応液を冷却し、水を加え不
溶物を濾別後、濾液を減圧濃縮した。得られた残渣
リカゲルカラムクロマトグラフィー(ワコーゲル、C2
00、クロロホルム)で精製し、表題の目的物を得た。
収量118.2mg(収率78%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−9.4゜(c 0.5,メタノール)
Without isolation, this was added to a solution of 24.0 mg of lithium aluminum hydride in 10 ml of THF, and the mixture was heated under reflux for 1.5 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (Wakogel, C2
00, chloroform) to give the title compound.
Yield: 118.2 mg (yield: 78%) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = −9.4 ゜ (c 0.5, methanol)

【0096】参考例12 メチル 9−ビシクロ[3.3.1]ノニリデンアセテ
ート ビシクロ[3.3.1]ノナン−9−オン0.50gと
メチルジエチルホスホノアセテート1.00mlの1,
2−ジメトキシエタン(DME)10ml溶液に水素化
ナトリウム(60%、油分散体)0.30gを加え室温
で3時間撹拌した。反応液に水を加え未反応の水素化ナ
トリウムを分解した後、DMEを減圧濃縮した。残渣を
クロロホルムで抽出し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して得られた残渣を
シリカゲルカラムクロマトグラフィー(ワコーゲル、C
200、ノルマルヘキサン:酢酸エチル=20:1)で
精製し、表題の目的物得た。収量 0.70g(収率1
00%)
Reference Example 12 Methyl 9-bicyclo [3.3.1] nonylidene acetate 0.50 g of bicyclo [3.3.1] nonan-9-one and 1.00 ml of methyl diethylphosphonoacetate
0.30 g of sodium hydride (60%, oil dispersion) was added to 10 ml of 2-dimethoxyethane (DME) solution, and the mixture was stirred at room temperature for 3 hours. After water was added to the reaction solution to decompose unreacted sodium hydride, DME was concentrated under reduced pressure. The residue was extracted with chloroform and dried over anhydrous sodium sulfate. After filtration of the drying agent, the residue obtained by concentrating the filtrate under reduced pressure was subjected to silica gel column chromatography (Wakogel, C
200, normal hexane: ethyl acetate = 20: 1) to obtain the title compound. Yield 0.70 g (Yield 1
00%)

【0097】参考例13 9−ビシクロ[3.3.1]ノニル酢酸メチルエステル メチル 9−ビシクロ[3.3.1]ノニリデンアセテ
ート0.70gのメタノール10ml溶液に10%Pd
−C0.07gを加え水素気流下、常温常圧にて2時間
接触還元を行った。反応液からPd−Cを濾別し、濾液
を減圧濃縮して表題の目的物を得た。収量0.67g
(収率94%)
Reference Example 13 9-Bicyclo [3.3.1] nonylacetic acid methyl ester 10% Pd was added to a solution of 0.70 g of methyl 9-bicyclo [3.3.1] nonylidene acetate in 10 ml of methanol.
0.07 g of -C was added, and catalytic reduction was performed at room temperature and normal pressure for 2 hours under a hydrogen stream. The Pd-C was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 0.67g
(94% yield)

【0098】参考例14 9−ビシクロ[3.3.1]ノニル酢酸 9−ビシクロ[3.3.1]ノニル酢酸メチルエステル
0.67gのメタノール15ml溶液に1N水酸化ナト
リウム水溶液5.2mlを加え室温で5時間撹拌した。
反応液を減圧濃縮し、得られた残渣に飽和重曹水を加え
エーテル洗浄した。水層を12N塩酸でpH1とし、酢
酸エチルで抽出して無水硫酸ナトリウムで乾燥した。乾
燥剤濾別後、濾液を減圧濃縮して表題の目的物を得た。
収量0.44g(収率71%)
Reference Example 14 9-Bicyclo [3.3.1] nonylacetic acid To a solution of 0.67 g of 9-bicyclo [3.3.1] nonylacetic acid methyl ester in 15 ml of methanol was added 5.2 ml of a 1N aqueous sodium hydroxide solution. Stir at room temperature for 5 hours.
The reaction solution was concentrated under reduced pressure, a saturated aqueous sodium hydrogen carbonate solution was added to the obtained residue, and the mixture was washed with ether. The aqueous layer was adjusted to pH 1 with 12N hydrochloric acid, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound.
Yield 0.44 g (71% yield)

【0099】実施例21 (1S)−3−[2−(ビシクロ[3.3.1]ノナン
−9−イル)エチル]−1,8,8−トリメチル−3−
アザビシクロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩100mgの塩化メチレ
ン10ml溶液にトリエチルアミン0.12mlを加え
0℃で30分攪拌した。そこへ、9−ビシクロ[3.
3.1]ノニル酢酸97.0mg、続いてWSC0.1
5gを加え、徐々に室温に戻し19時間攪拌した。反応
液を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−(ビシクロ[3.3.1]ノナンー9ーイル)アセチ
ル−1,8,8−トリメチル−3−アザビシクロ[3.
2.1]オクタンを得た。
Example 21 (1S) -3- [2- (Bicyclo [3.3.1] nonan-9-yl ) ethyl ] -1,8,8-trimethyl-3-
Azabicyclo [3.2.1] octane (1S) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (100 mg) was added to a solution of 100 mg of methylene chloride in 0.12 ml of triethylamine. Stir for 30 minutes. There, 9-bicyclo [3.
3.1] Nonylacetic acid 97.0 mg, followed by WSC 0.1
5 g was added, and the mixture was gradually returned to room temperature and stirred for 19 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-(Bicyclo [3.3.1] nonan-9-yl) acetyl-1,8,8-trimethyl-3-azabicyclo [3.
2.1] Octane was obtained.

【0100】これを単離することなく、水素化リチウム
アルミニウム41mgのTHF10ml溶液へ加え1時
間加熱還流した。反応液を冷却し、水を加え不溶物を濾
別後、濾液を減圧濃縮した。得られた残渣シリカゲル
カラムクロマトグラフィー(ワコーゲル、C200、ク
ロロホルム:アセトン=10:1〜5:1)で精製して
表題の目的物を得た。収量110mg(収率69%) 実施例1と同様の方法で処理し、塩酸塩を得た。 [α]D 25=−17.9゜(c 0.5,メタノール)
This was added without isolation to a solution of 41 mg of lithium aluminum hydride in 10 ml of THF and heated under reflux for 1 hour. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (Wakogel, C200, chloroform: acetone = 10: 1 to 5: 1) to obtain the title compound. Yield: 110 mg (69% yield) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = −17.9 ° (c 0.5, methanol)

【0101】実施例22 (1S)−3−(1−アダマンチルメチル)−1,8,
8−トリメチル−3−アザビシクロ[3.2.1]オク
タン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩100mgの塩化メチレ
ン5ml溶液にトリエチルアミン0.096mlを加え
0℃で30分攪拌した。そこへ、WSC0.13g、続
いて1−アダマンタンカルボン酸0.11gを加え、徐
々に室温に戻し15時間攪拌した。反応液を飽和食塩水
で洗浄し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別
後、濾液を減圧濃縮して粗(1S)−3−(1−アダマ
ンチルカルボニル)−1,8,8−トリメチル−3−ア
ザビシクロ[3.2.1]オクタンを得た。
Example 22 (1S) -3- (1-adamantylmethyl) -1,8,
8-Trimethyl-3-azabicyclo [3.2.1] octane (1S) -1,8,8-Trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (100 mg) was added to a solution of 100 mg of triethylamine in 5 ml of methylene chloride. 096 ml was added and the mixture was stirred at 0 ° C for 30 minutes. Thereto, 0.13 g of WSC and subsequently 0.11 g of 1-adamantanecarboxylic acid were added, and the mixture was gradually returned to room temperature and stirred for 15 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain crude (1S) -3- (1-adamantylcarbonyl) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane.

【0102】これを単離することなく、水素化リチウム
アルミニウム24.0mgのTHF10ml溶液へ加え
1.5時間加熱還流した。反応液を冷却し、水を加え不
溶物を濾別後、濾液を減圧濃縮した。得られた残渣
リカゲルカラムクロマトグラフィー(ワコーゲル、C2
00、クロロホルム)で精製して表題の目的物を得た。
収量71.2mg(収率45%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−10.5゜(c 0.5,メタノール)
Without isolation, this was added to a solution of lithium aluminum hydride (24.0 mg) in THF (10 ml), and the mixture was heated under reflux for 1.5 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (Wakogel, C2
00, chloroform) to give the title compound.
Yield: 71.2 mg (yield: 45%) Treatment was conducted in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -10.5 ゜ (c 0.5, methanol)

【0103】参考例15 メチル 5−ヒドロキシ−2−アダマンチリデンアセテ
ート メチルジエチルホスホノアセテート0.200mlのD
ME5ml溶液を−10℃に冷却し、水素化ナトリウム
(60%、油分散体)54.3mgを加え同温で1時間
撹拌した。そこへ、5−ヒドロキシ−2−アダマンタノ
ン150mgのDME5ml溶液を加え同温にて1.5
時間撹拌した。そこへ、水を加えDMEを減圧濃縮し、
残渣をクロロホルム抽出して無水硫酸ナトリウムで乾燥
した。乾燥剤濾別後、濾液を減圧濃縮し得られた残渣を
シリカゲルカラムクロマトグラフィー(ワコーゲル、C
200、クロロホルム)で精製して表題の目的物を得
た。収量180mg(収率90%)
Reference Example 15 Methyl 5-hydroxy-2-adamantylidene acetate Methyl diethylphosphonoacetate 0.200 ml of D
The ME 5 ml solution was cooled to −10 ° C., 54.3 mg of sodium hydride (60%, oil dispersion) was added, and the mixture was stirred at the same temperature for 1 hour. Thereto was added a solution of 5-hydroxy-2-adamantanone (150 mg) in DME (5 ml) and the mixture was heated at the same temperature for 1.5
Stirred for hours. There, water was added, and DME was concentrated under reduced pressure.
The residue was extracted with chloroform and dried over anhydrous sodium sulfate. After filtering off the desiccant, the filtrate was concentrated under reduced pressure and the resulting residue was subjected to silica gel column chromatography (Wakogel, C
(200, chloroform) to give the title compound. 180 mg (90% yield)

【0104】参考例16 5−ヒドロキシ−2−アダマンチル酢酸メチルエステル メチル 5−ヒドロキシ−2−アダマンチリデンアセテ
ート179.9mgのメタノール5ml溶液に10%P
d−C18.0mgを加え水素気流下、常温常圧にて
2.5時間接触還元を行った。反応液からPd−Cを濾
別し、濾液を減圧濃縮して目的物を無色油状物で得た。
収量166.3mg(収率92%)
REFERENCE EXAMPLE 16 Methyl 5-hydroxy-2-adamantyl acetic acid methyl ester 17% of methyl 5-hydroxy-2-adamantylidene acetate was added to a solution of 179.9 mg of 10% P in 5 ml of methanol.
18.0 mg of d-C was added, and the mixture was subjected to catalytic reduction under a hydrogen stream at normal temperature and normal pressure for 2.5 hours. Pd-C was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure to obtain the desired product as a colorless oil.
Yield 166.3 mg (92% yield)

【0105】参考例17 5−ヒドロキシ−2−アダマンチル酢酸 5−ヒドロキシ−2−アダマンチル酢酸メチルエステル
181.5mgのメタノール10ml溶液に2.5N水
酸化ナトリウム水溶液0.49mlを加え室温で14時
間撹拌した。反応液を減圧濃縮し、得られた残渣に飽和
重曹水を加えエーテル洗浄した。水層を12N塩酸でp
H1とし、酢酸エチルで抽出して無水硫酸ナトリウムで
乾燥した。乾燥剤濾別後、濾液を減圧濃縮して表題の目
的物を得た。収量150mg(収率88%)
Reference Example 17 5-Hydroxy-2-adamantyl acetic acid To a solution of 181.5 mg of methyl 5-hydroxy-2-adamantyl acetic acid in 10 ml of methanol was added 0.49 ml of a 2.5N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature for 14 hours. . The reaction solution was concentrated under reduced pressure, a saturated aqueous sodium hydrogen carbonate solution was added to the obtained residue, and the mixture was washed with ether. The aqueous layer is p
H1, extracted with ethyl acetate and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 150 mg (88% yield)

【0106】実施例23 (1S)−3−[−(5−ヒドロキシ−2−アダマン
チル)エチル]−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.44gの塩化メチレ
ン15ml溶液にトリエチルアミン0.38mlを加え
0℃で30分攪拌した。そこへ、WSC0.53g、続
いて5−ヒドロキシ−2−アダマンチル酢酸0.44g
を加え、徐々に室温に戻し14.5時間攪拌した。反応
液を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−(5−ヒドロキシ−2−アダマンチルアセチル)−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタンを得た。
[0106] Example 23 (1S) -3- [2 - (5- hydroxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1S) - 0.38 ml of triethylamine was added to a solution of 0.44 g of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 15 ml of methylene chloride, and the mixture was stirred at 0 ° C. for 30 minutes. There, 0.53 g of WSC, followed by 0.44 g of 5-hydroxy-2-adamantyl acetic acid.
Was gradually added to room temperature and stirred for 14.5 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-(5-hydroxy-2-adamantylacetyl)-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] Octane was obtained.

【0107】これを単離することなく、水素化リチウム
アルミニウム95.5mgのTHF30ml溶液へ加え
1.5時間加熱還流した。反応液を冷却し、水を加え不
溶物を濾別後、濾液を減圧濃縮した。得られた残渣
リカゲルカラムクロマトグラフィー(ワコーゲル、C2
00、クロロホルム:メタノール=150:1)で精製
して表題の目的物を得た。収量556mg(収率79
%)実施例1と同様の方法で処理し、塩酸塩を得た。 [α]D 25=−10.9゜(c 0.5,メタノール)
This was added without isolation to a solution of 95.5 mg of lithium aluminum hydride in 30 ml of THF, and the mixture was refluxed for 1.5 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (Wakogel, C2
00, chloroform: methanol = 150: 1) to give the title compound. Yield 556 mg (yield 79
%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -10.9 ゜ (c 0.5, methanol)

【0108】参考例18 5−メトキシ−2−アダマンタノン 5−ヒドロキシ−2−アダマンタノン100mg、ヨウ
化メチル0.113mlのTHF5ml溶液を0℃に冷
却し、水素化ナトリウム(60%、油分散体)48.2
mgを加え徐々に室温にもどし25時間攪拌した。反応
液に水を加えTHFのみを減圧濃縮した。得られた残渣
をクロロホルムで抽出し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮し、得られた残渣を
シリカゲルカラムクロマトグラフィー(ワコーゲル、C
200、ノルマルヘキサン:酢酸エチル=10:1)で
精製して表題の目的物を得た。収量57.7mg(収率
54%)
Reference Example 18 5-methoxy-2-adamantanone A solution of 100 mg of 5-hydroxy-2-adamantanone and 0.113 ml of methyl iodide in 5 ml of THF was cooled to 0 ° C., and sodium hydride (60%, oil dispersion 48.2)
mg was gradually added, and the mixture was gradually returned to room temperature and stirred for 25 hours. Water was added to the reaction solution, and only THF was concentrated under reduced pressure. The obtained residue was extracted with chloroform and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (Wakogel, C
200, normal hexane: ethyl acetate = 10: 1) to obtain the title compound. Yield 57.7 mg (54% yield)

【0109】参考例19 メチル 5−メトキシアダマンチリデンアセテート 5−メトキシ−2−アダマンタノン57.7mgとメチ
ルジエチルホスホノアセテート70.6μlのDME2
ml溶液を0℃に冷却し、水素化ナトリウム(60%、
油分散体)25.6mgを加え徐々に室温にもどし3.
5時間撹拌した。反応液に水を加え未反応の水素化ナト
リウムを分解した後、DMEを減圧濃縮した。残渣をク
ロロホルムで抽出し、無水硫酸ナトリウムで乾燥した。
乾燥剤濾別後、濾液を減圧濃縮して得られた残渣をシリ
カゲルカラムクロマトグラフィー(ワコーゲル、C20
0、ノルマルヘキサン:酢酸エチル=10:1)で精製
し、表題の目的物を得た。収量53.2mg(収率70
%)
Reference Example 19 DME2 containing 57.7 mg of methyl 5-methoxyadamantylidene acetate 5-methoxy-2-adamantanone and 70.6 μl of methyl diethylphosphonoacetate
ml solution was cooled to 0 ° C. and sodium hydride (60%,
2. Oil dispersion (25.6 mg) was added and gradually returned to room temperature.
Stir for 5 hours. After water was added to the reaction solution to decompose unreacted sodium hydride, DME was concentrated under reduced pressure. The residue was extracted with chloroform and dried over anhydrous sodium sulfate.
After filtration of the drying agent, the residue obtained by concentrating the filtrate under reduced pressure was subjected to silica gel column chromatography (Wakogel, C20).
0, normal hexane: ethyl acetate = 10: 1) to obtain the title compound. Yield 53.2 mg (yield 70
%)

【0110】参考例20 5−メトキシ−2−アダマンチル酢酸メチルエステル メチル 5−メトキシ−2−アダマンチリデンアセテ−
ト53.2mgのメタノール2ml溶液に10%Pd−
C5.3mgを加え水素気流下、常温常圧にて1.5時
間接触還元を行った。反応液からPd−Cを濾別し、濾
液を減圧濃縮して表題の目的物を得た。収量50.0m
g(収率93%)
Reference Example 20 methyl 5-methoxy-2-adamantyl acetic acid methyl ester methyl 5-methoxy-2-adamantylidene acete
10% Pd- in 5 ml solution of 53.2 mg of methanol
C. 5.3 mg was added, and catalytic reduction was carried out at room temperature and normal pressure for 1.5 hours under a hydrogen stream. The Pd-C was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 50.0m
g (93% yield)

【0111】参考例21 5−メトキシ−2−アダマンチル酢酸 5−メトキシ−2−アダマンチル酢酸メチルエステル5
0.0mgのメタノール2ml溶液に2.5N水酸化ナ
トリウム水溶液0.13mlを加え室温で7時間撹拌し
た。反応液を減圧濃縮し、得られた残渣に飽和重曹水を
加えエーテル洗浄した。水層を12N塩酸でpH1と
し、酢酸エチルで抽出して無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して表題の目的物を
得た。収量36.2g(収率77%)
Reference Example 21 5-methoxy-2-adamantyl acetic acid methyl 5-methoxy-2-adamantyl acetic acid 5
To a 2 mg solution of 0.0 mg of methanol was added 0.13 ml of 2.5N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature for 7 hours. The reaction solution was concentrated under reduced pressure, a saturated aqueous sodium hydrogen carbonate solution was added to the obtained residue, and the mixture was washed with ether. The aqueous layer was adjusted to pH 1 with 12N hydrochloric acid, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 36.2 m g (77% yield)

【0112】実施例24 (1S)−3−[−(5−メトキシ−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩33.7mgの塩化メチ
レン1ml溶液にトリエチルアミン29.3μlを加え
0℃で30分攪拌した。そこへ、5−メトキシ−2−ア
ダマンチル酢酸36.2mg、続いてWSC40.3m
gを加え、徐々に室温にもどし20.5時間攪拌した。
反応液を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾
燥した。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)
−3−(5−メトキシ−2−アダマンチルアセチル)−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタンを得た。
[0112] Example 24 (1S) -3- [2 - (5- methoxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1S) - To a solution of 33.7 mg of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 1 ml of methylene chloride was added 29.3 μl of triethylamine, and the mixture was stirred at 0 ° C. for 30 minutes. There, 36.2 mg of 5-methoxy-2-adamantylacetic acid, followed by WSC40.3m
g was added, and the mixture was gradually returned to room temperature and stirred for 20.5 hours.
The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give a crude (1S)
-3- (5-Methoxy-2-adamantylacetyl)-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] Octane was obtained.

【0113】これを単離することなく、水素化リチウム
アルミニウム7.4mgのTHF3ml溶液へ加え1.
5時間加熱還流した。反応液を冷却し、水を加え不溶物
を濾別後、濾液を減圧濃縮した。得られた残渣シリカ
ゲルカラムクロマトグラフィー(ワコーゲル、C20
0、クロロホルム:アセトン=20:1〜10:1)で
精製して表題の目的物を得た。収量32.1mg(収率
58%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−22.5°(c 0.1,メタノール)
Without isolation, this was added to a solution of 7.4 mg of lithium aluminum hydride in 3 ml of THF.
The mixture was refluxed for 5 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wako gel, C20).
0, chloroform: acetone = 20: 1 to 10: 1) to obtain the title compound. Yield: 32.1 mg (58% yield) Treatment was conducted in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -22.5 ° (c 0.1, methanol)

【0114】実施例25 (1S)−3−[−(5−クロロ−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1S)−3−[−(5−ヒドロキシ−2−アダマン
チル)エチル]−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン80.3mgに塩化チオ
ニル5mlを加え、4.5時間加熱還流した。反応液を
減圧濃縮し、得られた残渣に1N水酸化ナトリウムを加
えアルカリ性とした後、クロロホルム抽出した。抽出液
を無水硫酸ナトリウムで乾燥した後、乾燥剤濾別後、濾
液を減圧濃縮して得られた残渣シリカゲルカラムクロ
マトグラフィー(ワコーゲル、C200、クロロホル
ム:アセトン=20:1)で精製して表題の目的物を得
た。収量44.8mg(収率53%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−12.2゜(c 0.5,メタノ−ル)
[0114] Example 25 (1S) -3- [2 - (5- chloro-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1S) - 3- [2 - (5-hydroxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane 80.3mg in thionyl chloride 5ml was added, 4.5 hours Heated to reflux. The reaction solution was concentrated under reduced pressure, 1N sodium hydroxide was added to the obtained residue to make it alkaline, and the mixture was extracted with chloroform. The extract was dried over anhydrous sodium sulfate, filtered off with a desiccant, and the filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (Wako gel, C200, chloroform: acetone = 20: 1) to give the title. Was obtained. Yield: 44.8 mg (53% yield) The same treatment as in Example 1 was performed to obtain a hydrochloride. [Α] D 25 = 12.2 ゜ (c 0.5, methanol)

【0115】参考例22 メチル 5−フェニル−2−アダマンチリデンアセテ−
ト 5−フェニル−2−アダマンタノン86.1mgとメチ
ルジエチルホスホノアセテ−ト84.0μlのDME2
ml溶液を0℃に冷却し、水素化ナトリウム(60%、
油分散体)22.9mgを加え0℃で1.5時間撹拌し
た。反応液に水を加え未反応の水素化ナトリウムを分解
した後、DMEを減圧濃縮した。残渣をクロロホルムで
抽出し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別
後、濾液を減圧濃縮して得られた残渣をシリカゲルカラ
ムクロマトグラフィー(ワコーゲル、C200、ノルマ
ルヘキサン:酢酸エチル=30:1)で精製し、表題の
目的物を得た。収量55.3mg(収率52%)
Reference Example 22 Methyl 5-phenyl-2-adamantylideneacete
86.1 mg of 5-phenyl-2-adamantanone and 84.0 μl of methyl diethylphosphonoacetate in DME2
ml solution was cooled to 0 ° C. and sodium hydride (60%,
(Oil dispersion) 22.9 mg and stirred at 0 ° C. for 1.5 hours. After water was added to the reaction solution to decompose unreacted sodium hydride, DME was concentrated under reduced pressure. The residue was extracted with chloroform and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure, and the residue obtained was purified by silica gel column chromatography (Wako gel, C200, normal hexane: ethyl acetate = 30: 1) to obtain the title compound. Yield 55.3 mg (52% yield)

【0116】参考例23 5−フェニル−2−アダマンチル酢酸メチルエステル メチル 5−フェニル−2−アダマンチリデンアセテ−
ト55.3mgのメタノール2ml溶液に10%Pd−
C5.3mgを加え水素気流下、常温常圧にて2.5時
間接触還元を行った。反応液からPd−Cを濾別し、濾
液を減圧濃縮して表題の目的物を得た。収量55.7m
g(収率100%)
Reference Example 23 5-phenyl-2-adamantyl acetic acid methyl ester methyl 5-phenyl-2-adamantylidene acete
55.3 mg of 10% Pd-
C. 5.3 mg was added, and catalytic reduction was performed at room temperature and normal pressure for 2.5 hours under a hydrogen stream. The Pd-C was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 55.7m
g (100% yield)

【0117】参考例24 5−フェニル−2−アダマンチル酢酸 5−フェニル−2−アダマンチル酢酸メチルエステル5
5.7mgのメタノール3ml溶液に2.5N水酸化ナ
トリウム水溶液0.12mlを加え室温で14.5時間
撹拌した。反応液を減圧濃縮し、得られた残渣に飽和重
曹水を加えエーテル洗浄した。水層を12N塩酸でpH
1とし酢酸エチルで抽出して無水硫酸ナトリウムで乾燥
した。乾燥剤濾別後、濾液を減圧濃縮して表題の目的物
を得た。収量22.6g(収率43%)
Reference Example 24 5-Phenyl-2-adamantyl acetic acid methyl 5-phenyl-2-adamantyl acetic acid 5
To a solution of 5.7 mg in 3 ml of methanol was added 0.12 ml of a 2.5 N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature for 14.5 hours. The reaction solution was concentrated under reduced pressure, a saturated aqueous sodium hydrogen carbonate solution was added to the obtained residue, and the mixture was washed with ether. PH of aqueous layer with 12N hydrochloric acid
The extract was extracted with ethyl acetate and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 22.6 m g (43% yield)

【0118】実施例26 (1S)−3−[−(5−フェニル−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩15.9mgの塩化メチ
レン1ml溶液にトリエチルアミン14.0μlを加え
0℃で30分攪拌した。そこへ、5−フェニル−2−ア
ダマンチル酢酸22.6mg、続いてWSC19.3m
gを加え、徐々に室温にもどし64時間攪拌した。反応
液を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−(5−フェニル−2−アダマンチルアセチル)−1,
8,8−トリメチル−3−アザビシクロ[3.2.1]
オクタンを得た。
[0118] Example 26 (1S) -3- [2 - (5- phenyl-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1S) - To a solution of 15.9 mg of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 1 ml of methylene chloride was added 14.0 μl of triethylamine, and the mixture was stirred at 0 ° C. for 30 minutes. There, 22.6 mg of 5-phenyl-2-adamantylacetic acid, followed by 19.3 m of WSC
g was added, and the mixture was gradually returned to room temperature and stirred for 64 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-(5-phenyl-2-adamantylacetyl) -1,
8,8-Trimethyl-3-azabicyclo [3.2.1]
Octane obtained.

【0119】これを単離することなく、水素化リチウム
アルミニウム3.8mgのTHF3ml溶液へ加え1.
5時間加熱還流した。反応液を冷却し、水を加え不溶物
を濾別後、濾液を減圧濃縮した。得られた残渣シリカ
ゲルカラムクロマトグラフィー(ワコーゲル、C20
0、クロロホルム:アセトン=20:1)で精製して表
題の目的物を得た。収量7.0mg(収率21%) 実施例1と同様の方法で処理し、塩酸塩を得た。
Without isolation, 3.8 mg of lithium aluminum hydride was added to a solution of 3.8 mg of THF.
The mixture was refluxed for 5 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wako gel, C20).
0, chloroform: acetone = 20: 1) to give the title compound. Yield: 7.0 mg (Yield: 21%) Treatment was carried out in the same manner as in Example 1 to obtain a hydrochloride.

【0120】参考例25メチル 4−ヒドロキシ−2−アダマンチリデンアセテ
ート 4−ヒドロキシ−2−アダマンタノン536.1mgと
メチルジエチルホスホノアセテ−ト0.72mlのDM
E20ml溶液を−10℃に冷却し、水素化ナトリウム
(60% 油分散体)259mgを加え同温で1.5時
間撹拌した。反応液に水を加え、未反応の水素化ナトリ
ウムを分解した後、DMEを減圧濃縮した。残渣をクロ
ロホルムで抽出し、無水硫酸ナトリウムで乾燥した。乾
燥剤濾別後、濾液を減圧濃縮して得られた残渣をシリカ
ゲルカラムクロマトグラフィー(ワコーゲル、C20
0、クロロホルム)で精製し、表題の目的物を得た。収
量0.51g(収率71%)
Reference Example 25 Methyl 4-hydroxy-2-adamantylidene acetate 536.1 mg of 4-hydroxy-2-adamantanone and 0.72 ml of methyl diethylphosphonoacetate in DM
E20 ml solution was cooled to −10 ° C., 259 mg of sodium hydride (60% oil dispersion) was added, and the mixture was stirred at the same temperature for 1.5 hours. Water was added to the reaction solution to decompose unreacted sodium hydride, and then DME was concentrated under reduced pressure. The residue was extracted with chloroform and dried over anhydrous sodium sulfate. After filtration of the drying agent, the residue obtained by concentrating the filtrate under reduced pressure was subjected to silica gel column chromatography (Wakogel, C20).
0, chloroform) to give the title compound. 0.51 g (71% yield)

【0121】参考例26 4−ヒドロキシ−2−アダマンチル酢酸メチルエステルメチル 4−ヒドロキシ−2−アダマンチリデンアセテ
−ト0.51gのメタノール20ml溶液に10%Pd
−C51mgを加え水素気流下、常温常圧にて1時間接
触還元を行った。反応液からPd−Cを濾別し、濾液を
減圧濃縮して表題の目的物を得た。収量0.47g(収
率92%)
Reference Example 26 4-Hydroxy-2-adamantyl acetic acid methyl ester 10% Pd was added to a solution of 0.51 g of methyl 4-hydroxy-2-adamantylidene acetate in 20 ml of methanol.
-C 51 mg was added, and catalytic reduction was performed at room temperature and normal pressure for 1 hour under a hydrogen stream. The Pd-C was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 0.47 g (92% yield)

【0122】参考例27 4−ヒドロキシ−2−アダマンチル酢酸 4−ヒドロキシ−2−アダマンチル酢酸メチルエステル
0.47gのメタノール15ml溶液に2.5N水酸化
ナトリウム水溶液1.26mlを加え室温で5.5時間
撹拌した。反応液を減圧濃縮し、得られた残渣に飽和重
曹水を加えエーテル洗浄した。水層を12N塩酸でpH
1とし酢酸エチルで抽出して無水硫酸ナトリウムで乾燥
した。乾燥剤濾別後、濾液を減圧濃縮して表題の目的物
を得た。収量0.26g(収率59%)
Reference Example 27 4-Hydroxy-2-adamantyl acetic acid To a solution of 0.47 g of 4-hydroxy-2-adamantyl acetic acid methyl ester in 15 ml of methanol was added 1.26 ml of a 2.5N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature for 5.5 hours. Stirred. The reaction solution was concentrated under reduced pressure, a saturated aqueous sodium hydrogen carbonate solution was added to the obtained residue, and the mixture was washed with ether. PH of aqueous layer with 12N hydrochloric acid
The extract was extracted with ethyl acetate and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 0.26 g (59% yield)

【0123】実施例27 (1S)−3−[−(4−ヒドロキシ−2−アダマン
チル)エチル]−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.26gの塩化メチレ
ン5ml溶液にトリエチルアミン0.23mlを加え0
℃で30分攪拌した。そこへ、4−ヒドロキシ−2−ア
ダマンチル酢酸0.26g、続いてWSC0.31gを
加え、徐々に室温にもどし25時間攪拌した。反応液を
飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。
乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3−
(4−ヒドロキシ−2−アダマンチルアセチル)−1,
8,8−トリメチル−3−アザビシクロ[3.2.1]
オクタンを得た。
[0123] Example 27 (1S) -3- [2 - (4- hydroxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1S) - To a solution of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (0.26 g) in methylene chloride (5 ml) was added triethylamine (0.23 ml).
Stirred at 30 ° C for 30 minutes. Thereto, 0.26 g of 4-hydroxy-2-adamantylacetic acid and subsequently 0.31 g of WSC were added, and the mixture was gradually returned to room temperature and stirred for 25 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate.
After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3-.
(4-hydroxy-2-adamantylacetyl) -1,
8,8-Trimethyl-3-azabicyclo [3.2.1]
Octane obtained.

【0124】これを単離することなく、水素化リチウム
アルミニウム70.5mgのTHF25ml溶液へ加え
1.5時間加熱還流した。反応液を冷却し、水を加え不
溶物を濾別後、濾液を減圧濃縮した。得られた残渣
リカゲルカラムクロマトグラフィー(ワコーゲル、C2
00、クロロホルム:メタノール=150:1)で精製
して表題の目的物を得た。収量160.5mg(収率3
9%) 実施例1と同様の方法で処理し、塩酸塩を得た。
Without isolation, this was added to a solution of 70.5 mg of lithium aluminum hydride in 25 ml of THF, and the mixture was heated under reflux for 1.5 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (Wakogel, C2
00, chloroform: methanol = 150: 1) to give the title compound. Yield 160.5 mg (Yield 3
9%) The product was treated in the same manner as in Example 1 to obtain a hydrochloride.

【0125】参考例28 メチル 4−フェニル−2−アダマンチリデンアセテ−
ト 4−フェニル−2−アダマンタノン1.43gとメチル
ジエチルホスホノアセテ−ト1.74mlのDME50
ml溶液に水素化ナトリウム(60%、油分散体)50
6mgを加え、室温で23.5時間撹拌した。反応液に
エ−テルを加え水洗し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して得られた残渣を
フラッシュシリカゲルカラムクロマトグラフィー(メル
ク、シリカゲル60、230〜400メッシュ、ノルマ
ルヘキサン:酢酸エチル=8:1)で精製し、表題の目
的物を得た。収量866mg(収率49%)
Reference Example 28 Methyl 4-phenyl-2-adamantylideneacete
DME50 of 1.43 g of 4-phenyl-2-adamantanone and 1.74 ml of methyldiethylphosphonoacetate
sodium hydride (60%, oil dispersion) 50 ml solution
6 mg was added, and the mixture was stirred at room temperature for 23.5 hours. Ether was added to the reaction solution, washed with water, and dried over anhydrous sodium sulfate. After filtering off the drying agent, the residue obtained by concentrating the filtrate under reduced pressure was purified by flash silica gel column chromatography (Merck, silica gel 60, 230-400 mesh, normal hexane: ethyl acetate = 8: 1) to obtain the title compound. I got something. Yield 866 mg (49% yield)

【0126】参考例29 4−フェニル−2−アダマンチル酢酸メチルエステル メチル 4−フェニル−2−アダマンチリデンアセテ−
ト838mgのメタノ−ル15ml溶液に10%Pd−
C100mgを加え、水素気流下常温常圧で1時間接触
還元を行った。反応液からPd−Cを濾別し、濾液を減
圧濃縮して表題の目的物を得た。収量838mg(収率
96%)
REFERENCE EXAMPLE 29 4-Phenyl-2-adamantylacetic acid methyl ester methyl 4-phenyl-2-adamantylideneacetate
10% Pd- in a solution of 838 mg of methanol in 15 ml of methanol
100 mg of C was added, and catalytic reduction was performed at room temperature and normal pressure for 1 hour under a hydrogen stream. The Pd-C was filtered off from the reaction solution, and the filtrate was concentrated under reduced pressure to obtain the title compound. 838 mg (96% yield)

【0127】参考例30 4−フェニル−2−アダマンチル酢酸 4−フェニル−2−アダマンチル酢酸メチルエステル8
38mgのメタノール20ml溶液に1N水酸化ナトリ
ウム水溶液6mlを加え室温で13.5時間撹拌した。
反応液を減圧濃縮し、得られた残渣に飽和重曹水を加え
エーテル洗浄した。水層を12N塩酸でpH1とし、塩
化メチレンで抽出して無水硫酸ナトリウムで乾燥した。
乾燥剤濾別後、濾液を減圧濃縮して表題の目的物を得
た。収量774mg(収率97%)
Reference Example 30 4-phenyl-2-adamantyl acetic acid methyl 4-phenyl-2-adamantyl acetic acid 8
6 ml of a 1N aqueous sodium hydroxide solution was added to a solution of 38 mg of methanol in 20 ml, and the mixture was stirred at room temperature for 13.5 hours.
The reaction solution was concentrated under reduced pressure, a saturated aqueous sodium hydrogen carbonate solution was added to the obtained residue, and the mixture was washed with ether. The aqueous layer was adjusted to pH 1 with 12N hydrochloric acid, extracted with methylene chloride, and dried over anhydrous sodium sulfate.
After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 774 mg (97% yield)

【0128】実施例28 (1S)−3−[2−(4−フェニル−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩815mgの塩化メチレ
ン30ml溶液にトリエチルアミン1.00mlを加え
0℃で30分攪拌した。そこへ、4−フェニル−2−ア
ダマンチル酢酸774mg、続いてWSC1.65gを
加え、徐々に室温にもどし16.5時間攪拌した。反応
液を1N塩酸で洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−(4−フェニル−2−アダマンチルアセチル)−1,
8,8−トリメチル−3−アザビシクロ[3.2.1]
オクタンを得た。
Example 28 (1S) -3- [2- (4-Phenyl-2-adamantyl) ethyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1S)- Triethylamine (1.00 ml) was added to a solution of 815 mg of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 30 ml of methylene chloride, and the mixture was stirred at 0 ° C. for 30 minutes. Thereto, 774 mg of 4-phenyl-2-adamantylacetic acid and subsequently 1.65 g of WSC were added, and the mixture was gradually returned to room temperature and stirred for 16.5 hours. The reaction solution was washed with 1N hydrochloric acid and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-(4-phenyl-2-adamantylacetyl) -1,
8,8-Trimethyl-3-azabicyclo [3.2.1]
Octane obtained.

【0129】これを単離することなく、水素化リチウム
アルミニウム229mgのTHF30ml溶液へ加え1
時間加熱還流した。反応液を冷却し、水と2.5N水酸
化ナトリウムを加え不溶物を濾別後、濾液を減圧濃縮し
た。得られた残渣をフラッシュシリカゲルカラムクロマ
トグラフィー(メルク、シリカゲル60、230〜40
0メッシュ、クロロホルム)で精製して表題の目的物を
得た。収量878mg(収率78%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−8.9゜(c 0.5,メタノ−ル)
Without isolation, this was added to a solution of 229 mg of lithium aluminum hydride in 30 ml of THF, and 1
Heated to reflux for an hour. The reaction solution was cooled, water and 2.5N sodium hydroxide were added, and the insoluble material was separated by filtration. The filtrate was concentrated under reduced pressure. The obtained residue is subjected to flash silica gel column chromatography (Merck, silica gel 60, 230 to 40).
(0 mesh, chloroform) to give the title compound. Yield 878 mg (yield 78%) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = -8.9 ゜ (c 0.5, methanol)

【0130】実施例29 (1R)−3−[2−(4−フェニル−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.48gと4−フェニ
ル−2−アダマンチル酢酸0.59gから実施例28の
化合物の合成と同様に反応し、シリカゲルカラムクロマ
トグラフィー(ワコーゲル、C200、クロロホルム)
で精製し、表題の目的物を得た。収量0.69g(収率
82%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+9.5゜(c 0.5,メタノ−ル)
Example 29 (1R) -3- [2- (4-Phenyl-2-adamantyl) ethyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1R)- Reaction was conducted in the same manner as in the synthesis of the compound of Example 28 from 0.48 g of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 0.59 g of 4-phenyl-2-adamantylacetic acid, Silica gel column chromatography (Wako gel, C200, chloroform)
And the title compound was obtained. Yield: 0.69 g (82% yield) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = + 9.5 ゜ (c 0.5, methanol)

【0131】実施例30 (1R)−3−[−(5−メトキシ−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩28.4mgと5−メト
キシ−2−アダマンチル酢酸36.9mgから実施例2
4の化合物の合成と同様に反応し、シリカゲルカラムク
ロマトグラフィー(ワコーゲル、C200、クロロホル
ム:アセトン=10:1)で精製し、表題の目的物を得
た。収量34.1mg(収率66%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+18.7゜(c 0.5,メタノ−ル)
[0131] Example 30 (1R) -3- [2 - (5- methoxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1R) - Example 2 from 28.4 mg of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 36.9 mg of 5-methoxy-2-adamantylacetic acid
The reaction was carried out in the same manner as in the synthesis of the compound No. 4 and purified by silica gel column chromatography (Wako gel, C200, chloroform: acetone = 10: 1) to obtain the title compound. Yield: 34.1 mg (66% yield) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = + 18.7 ° (c 0.5, methanol)

【0132】実施例31 (1R)−3−[−(5−ヒドロキシ−2−アダマン
チル)エチル]−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.15gと5−ヒドロ
キシ−2−アダマンチル酢酸0.15gから実施例23
の化合物の合成と同様に反応し、シリカゲルカラムクロ
マトグラフィー(ワコーゲル、C200、クロロホル
ム:メタノ−ル=100:1)で精製し、表題の目的物
を得た。収量0.16g(収率66%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+11.2゜(c 0.5,メタノール)
[0132] Example 31 (1R) -3- [2 - (5- hydroxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1R) - Example 23 was prepared from 0.15 g of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 0.15 g of 5-hydroxy-2-adamantyl acetic acid.
And purified by silica gel column chromatography (Wakogel, C200, chloroform: methanol = 100: 1) to obtain the title compound. Yield: 0.16 g (66% yield) The same treatment as in Example 1 was performed to obtain a hydrochloride. [Α] D 25 = + 11.2 ゜ (c 0.5, methanol)

【0133】実施例32 (1R)−3−[−(5−クロロ−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1R)−3−[−(5−ヒドロキシ−2−アダマン
チル)エチル]−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン82.8mgに塩化チオ
ニル5mlを加え、5時間加熱還流した。反応液を減圧
濃縮し、得られた残渣に1N水酸化ナトリウムを加えア
ルカリ性とした後、クロロホルム抽出した。抽出液を無
水硫酸ナトリウムで乾燥した後、乾燥剤濾別後、濾液を
減圧濃縮して得られた残渣をシリカゲルカラムクロマト
グラフィー(ワコーゲル、C200、クロロホルム:ア
セトン=20:1)で精製して表題の目的物を得た。収
量48.1mg(収率55%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+13.6゜(c 0.5,メタノ−ル)
[0133] Example 32 (1R) -3- [2 - (5- chloro-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1R) - 3- [2 - (5-hydroxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane 82.8mg in thionyl chloride 5ml was added, heated under reflux for 5 hours did. The reaction solution was concentrated under reduced pressure, 1N sodium hydroxide was added to the obtained residue to make it alkaline, and the mixture was extracted with chloroform. The extract was dried over anhydrous sodium sulfate, filtered off with a desiccant, and the filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (Wako gel, C200, chloroform: acetone = 20: 1) to give the title. Was obtained. Yield: 48.1 mg (55% yield) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = + 13.6 ° (c 0.5, methanol)

【0134】実施例33 (1R)−3−[−(5−フェニル−2−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩37.2mgと5−フェ
ニル−2−アダマンチル酢酸53.0mgから実施例2
6の化合物の合成と同様に反応し、シリカゲルカラムク
ロマトグラフィー(ワコーゲル、C200、クロロホル
ム:アセトン=20:1)で精製し、表題の目的物を得
た。収量11.0g(収率13%) 実施例1と同様の方法で処理し、塩酸塩を得た。
[0134] Example 33 (1R) -3- [2 - (5- phenyl-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1R) - Example 2 from 37.2 mg of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 53.0 mg of 5-phenyl-2-adamantylacetic acid
The reaction was carried out in the same manner as in the synthesis of the compound No. 6 and purified by silica gel column chromatography (Wako gel, C200, chloroform: acetone = 20: 1) to obtain the title compound. Yield 11.0 m g (13% yield) was treated in the same manner as in Example 1 to obtain the hydrochloride.

【0135】実施例34 (1R)−3−[−(4−ヒドロキシ−2−アダマン
チル)エチル]−1,8,8−トリメチル−3−アザビ
シクロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.22gと4−ヒドロ
キシ−2−アダマンチル酢酸0.37gから実施例27
の化合物の合成と同様に反応し、シリカゲルカラムクロ
マトグラフィー(ワコーゲル、C200、クロロホル
ム:メタノ−ル=150:1)で精製し、表題の目的物
を得た。収量74mg(収率19%) 実施例1と同様の方法で処理し、塩酸塩を得た。
[0135] Example 34 (1R) -3- [2 - (4- hydroxy-2-adamantyl) ethyl] -1,8,8- trimethyl-3-azabicyclo [3.2.1] octane (1R) - Example 27 was prepared from 0.22 g of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 0.37 g of 4-hydroxy-2-adamantyl acetic acid.
And purified by silica gel column chromatography (Wakogel, C200, chloroform: methanol = 150: 1) to give the title compound. Yield: 74 mg (19% yield) The product was treated in the same manner as in Example 1 to obtain a hydrochloride.

【0136】実施例35 (1R)−3−[2−(3−メチル−1−アダマンチ
ル)エチル]−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩0.50gと3−メチル
−1−アダマンチル酢酸0.65gから実施例19の化
合物の合成と同様に反応し、シリカゲルカラムクロマト
グラフィー(ワコーゲル、C200、クロロホルム)で
精製し、表題の目的物を得た。収量0.74g(収率8
5%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+10.6゜(c 0.5、メタノール)
Example 35 (1R) -3- [2- (3-Methyl-1-adamantyl) ethyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1R)- Reaction was conducted in the same manner as in the synthesis of the compound of Example 19 from 0.50 g of 1,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride and 0.65 g of 3-methyl-1-adamantylacetic acid, Purification by silica gel column chromatography (Wako gel, C200, chloroform) gave the title compound. 0.74 g (yield 8
5%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = + 10.6 ゜ (c 0.5, methanol)

【0137】実施例36 (1S)−3−[3−(2−アダマンチル)−1−プロ
ピル]−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩50.0mgの塩化メチ
レン3ml溶液にトリエチルアミン44.1μlを加え
0℃で30分攪拌した。そこへ、3−(2−アダマンチ
ル)プロピオン酸60.4mg、続いてWSC65.7
mgを加え、徐々に室温に戻し13時間攪拌した。反応
後、飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し
た。乾燥剤濾別後、濾液を減圧濃縮して粗(1S)−3
−[3−(2−アダマンチル)プロピオニル]−1,
8,8−トリメチル−3−アザビシクロ[3.2.1]
オクタンを得た。
Example 36 (1S) -3- [3- (2-Adamantyl) -1-propyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1S) -1 To a solution of 50.0 mg of 5,8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 3 ml of methylene chloride was added 44.1 μl of triethylamine, and the mixture was stirred at 0 ° C. for 30 minutes. There, 60.4 mg of 3- (2-adamantyl) propionic acid, followed by WSC65.7
mg was added, and the mixture was gradually returned to room temperature and stirred for 13 hours. After the reaction, the reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3.
-[3- (2-adamantyl) propionyl] -1,
8,8-Trimethyl-3-azabicyclo [3.2.1]
Octane obtained.

【0138】これを単離することなく、水素化リチウム
アルミニウム12.0mgのTHF5ml溶液へ加え3
時間加熱還流した。反応後、冷却し、水を加え不溶物を
濾別し、濾液を減圧濃縮した。得られた残渣をシリカゲ
ルカラムクロマトグラフィ−(ワコ−ゲル、C200、
クロロホルム)で精製し、表題の目的物を得た。収量6
1.6mg(収率71%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−9.8゜(c 0.5、メタノール)
This was added to a solution of 12.0 mg of lithium aluminum hydride in 5 ml of THF without isolation, and
Heated to reflux for an hour. After the reaction, the reaction mixture was cooled, water was added, insolubles were removed by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (Wako-gel, C200,
Purification with chloroform) gave the title compound. Yield 6
1.6 mg (yield 71%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = -9.8 ゜ (c 0.5, methanol)

【0139】実施例37 (1R)−3−[3−(2−アダマンチル)−1−プロ
ピル]−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩50.0mgと3−(2
−アダマンチル)プロピオン酸60.4mgから実施例
36の化合物の合成と同様に反応し、シリカゲルカラム
クロマトグラフィ−(ワコ−ゲル、C200、クロロホ
ルム)で精製し、表題の目的物を得た。収量59.0m
g(収率68%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+9.6゜(c 0.5、メタノール)
Example 37 (1R) -3- [3- (2-Adamantyl) -1-propyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1R) -1 , 8,8-Trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (50.0 mg) and 3- (2
The reaction was carried out in the same manner as in the synthesis of the compound of Example 36 from 60.4 mg of -adamantyl) propionic acid, followed by purification by silica gel column chromatography (Wako-gel, C200, chloroform) to obtain the title compound. Yield 59.0m
g (yield: 68%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = + 9.6 ゜ (c 0.5, methanol)

【0140】実施例38 (1S)−3−[2−(3−ノルアダマンチル)エチ
ル]−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩50.0mgの塩化メチ
レン3ml溶液にトリエチルアミン44.1μlを加え
0℃で30分攪拌した。そこへ、WSC65.7mg、
続いて3−ノルアダマンチル酢酸52.2mgを加え、
徐々に室温に戻し18時間攪拌した。反応液を飽和食塩
水で洗浄し、無水硫酸ナトリウムで乾燥した。乾燥剤濾
別後、濾液を減圧濃縮して粗(1S)−3−(3−ノル
アダマンチルアセチル)−1,8,8−トリメチル−3
−アザビシクロ[3.2.1]オクタンを得た。
Example 38 (1S) -3- [2- (3-Noradamantyl) ethyl] -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane (1S) -1,8 To a solution of 50.0 mg of 8,8-trimethyl-3-azabicyclo [3.2.1] octane hydrochloride in 3 ml of methylene chloride was added 44.1 µl of triethylamine, and the mixture was stirred at 0 ° C for 30 minutes. There, WSC65.7mg,
Subsequently, 52.2 mg of 3-noradamantyl acetic acid was added,
The mixture was gradually returned to room temperature and stirred for 18 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtration of the drying agent, the filtrate was concentrated under reduced pressure to give crude (1S) -3- (3-noradamantylacetyl) -1,8,8-trimethyl-3.
-Azabicyclo [3.2.1] octane was obtained.

【0141】これを単離することなく、水素化リチウム
アルミニウム12.0mgのTHF5ml溶液へ加え3
時間加熱還流した。反応液を冷却し、水を加え不溶物を
濾別後、濾液を減圧濃縮した。得られた残渣をシリカゲ
ルカラムクロマトグラフィー(ワコーゲル、C200、
クロロホルム)で精製して表題の目的物を得た。収量6
5.9mg(収率83%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−9.8゜(c 0.5,メタノール)
This was added without isolation to a solution of 12.0 mg of lithium aluminum hydride in 5 ml of THF.
Heated to reflux for an hour. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wakogel, C200,
Purification with chloroform) gave the title compound. Yield 6
5.9 mg (83% yield) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = −9.8 ゜ (c 0.5, methanol)

【0142】実施例39 (1S)−3−(2−アダマンチルメチル)−1,8,
8−トリメチル−3−アザビシクロ[3.2.1]オク
タン (1S)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩100mgの塩化メチレ
ン5ml溶液にトリエチルアミン0.096mlを加え
0℃で30分撹拌した。そこへ、2−アダマンタンカル
ボン酸0.11g、続いてWSC0.13gを加え、徐
々に室温に戻し17時間撹拌した。反応液を飽和食塩水
で洗浄し、無水硫酸ナトリウムで乾燥した。乾燥剤濾別
後、濾液を減圧濃縮して粗(1S)−3−(2−アダマ
ンチルカルボニル)ー1,8,8−トリメチル−3−ア
ザビシクロ[3.2.1]オクタンを得た。
Example 39 (1S) -3- (2-Adamantylmethyl) -1,8,
8-Trimethyl-3-azabicyclo [3.2.1] octane (1S) -1,8,8-Trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (100 mg) was added to a solution of 100 mg of triethylamine in 5 ml of methylene chloride. 096 ml was added and the mixture was stirred at 0 ° C for 30 minutes. Thereto, 0.11 g of 2-adamantanecarboxylic acid and subsequently 0.13 g of WSC were added, and the mixture was gradually returned to room temperature and stirred for 17 hours. The reaction solution was washed with saturated saline and dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure to obtain crude (1S) -3- (2-adamantylcarbonyl) -1,8,8-trimethyl-3-azabicyclo [3.2.1] octane.

【0143】これを単離することなく、水素化リチウム
アルミニウム24.0mgのTHF10ml溶液へ加え
2時間加熱還流した。反応液を冷却し、水を加え不溶物
濾別後、濾液を減圧濃縮した。得られた残渣をシリカゲ
ルカラムクロマトグラフィー(ワコーゲル、C200、
クロロホルム)で精製して表題の目的物を得た。収量5
3.0mg(収率33%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=−9.7゜(c 0.5,メタノール)
This was added without isolation to a solution of lithium aluminum hydride (24.0 mg) in THF (10 ml) and heated under reflux for 2 hours. The reaction solution was cooled, water was added, and the insoluble material was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography (Wakogel, C200,
Purification with chloroform) gave the title compound. Yield 5
3.0 mg (yield: 33%) The product was treated in the same manner as in Example 1 to obtain a hydrochloride. [Α] D 25 = −9.7 ゜ (c 0.5, methanol)

【0144】実施例40 (1R)−3−(2−アダマンチルメチル)−1,8,
8−トリメチル−3−アザビシクロ[3.2.1]オク
タン (1R)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタン塩酸塩100mgと2−アダマ
ンタンカルボン酸0.11gから実施例39の化合物の
合成と同様に反応し、シリカゲルカラムクロマトグラフ
ィー(ワコーゲル、C200、クロロホルム)で精製し
て表題の目的物を得た。収量55.2mg(収率34
%) 実施例1と同様の方法で処理し、塩酸塩を得た。 〔α〕D 25=+10.3゜(c 0.5,メタノール)
Example 40 (1R) -3- (2-Adamantylmethyl) -1,8,
8-Trimethyl-3-azabicyclo [3.2.1] octane (1R) -1,8,8-Trimethyl-3-azabicyclo [3.2.1] octane hydrochloride (100 mg) and 2-adamantanecarboxylic acid (0.11 g) And purified by silica gel column chromatography (Wako gel, C200, chloroform) to give the title compound. Yield 55.2 mg (yield 34
%) The same treatment as in Example 1 was carried out to obtain a hydrochloride. [Α] D 25 = + 10.3 ゜ (c 0.5, methanol)

【0145】実施例41 注射剤の製造 (1S)−3−[2−(2−アダマンチル)エチル]−
1,8,8−トリメチル−3−アザビシクロ[3.2.
1]オクタン塩酸塩1.0gを注射用蒸留水1Lに溶解
し、1N水酸化ナトリウム水溶液でpH6−7に調節し
た後、滅菌し、これをアンプルに5mlずつ充填して注
射剤を得た。
Example 41 Production of Injection (1S) -3- [2- (2-Adamantyl) ethyl]-
1,8,8-Trimethyl-3-azabicyclo [3.2.
1] 1.0 g of octane hydrochloride was dissolved in 1 L of distilled water for injection, adjusted to pH 6-7 with a 1N aqueous solution of sodium hydroxide, sterilized, and filled into ampoules in 5 ml portions to obtain injections.

【0146】実施例42 錠剤の製造 (1S)−3−[2−(2−アダマンチル)エチル]−
1,8,8トリメチ ル−3−アザビシクロ[3.2.1]オクタン塩酸塩 50.0mg とうもろこし澱粉 40.0mg 結晶セルロース 80.0mg ステアリン酸マグネシウム 0.5mg タルク 29.5mg の組成からなる1錠200mgの錠剤を乾式打錠により
得た。
Example 42 Preparation of tablet (1S) -3- [2- (2-adamantyl) ethyl]-
1,8,8 - trimethylene-3-azabicyclo [3.2.1] 1 having a composition of octane hydrochloride 50.0mg Corn starch 40.0mg crystalline cellulose 80.0mg Magnesium stearate 0.5mg Talc 29.5mg Tablets 200 mg tablets were obtained by dry tableting.

【0147】[0147]

【表3】 [Table 3]

【0148】[0148]

【表4】 [Table 4]

Claims (8)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 一般式 【化1】 〔式中、Rは式 【化2】 (式中、R1 は水素原子、低級アルキル基、低級アルコ
キシ基、水酸基、ハロゲン原子または置換基を有してい
てもよいフェニル基を示し、nは0または1を示す)で
表される基、低級アルキル基で置換していてもよい炭素
数5〜8個のシクロアルキル基、ノルボルニル基または
ビシクロ[3.3.1]ノニル基を示し、mは0〜4の
整数を示し、C* は不斉炭素原子を示す〕で表されるア
ゼピン誘導体またはその
1. A compound of the general formula [Wherein R is a compound of the formula: (Wherein, R 1 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group, a halogen atom or a phenyl group which may have a substituent, and n represents 0 or 1) a lower alkyl group substituted with an optionally several 5-8 cycloalkyl group having a carbon also shows a norbornyl group or a bicyclo [3.3.1] nonyl group, m represents an integer of 0 to 4, C * Represents an asymmetric carbon atom], or a salt thereof .
【請求項2】 1 が水素原子である請求項1記載のア
ゼピン誘導体またはその塩
2. The method according to claim 1 , wherein R 1 is a hydrogen atom.
Zepin derivatives or salts thereof .
【請求項3】 (1S)−3−〔2−(2−アダマンチ
ル)エチル〕−1,8,8−トリメチル−3−アザビシ
クロ[3.2.1]オクタンである請求項1 または2記
載のアゼピン誘導体またはその塩
3. ( 1S) -3- [2- (2-adamanche)
Ru) ethyl] -1,8,8-trimethyl-3-azabisi
3. The method according to claim 1, wherein the compound is black [3.2.1] octane.
Azepine derivatives or salts thereof .
【請求項4】 一般式 【化3】 式中、Rは式 【化4】 式中、R 1 は水素原子、低級アルキル基、低級アルコ
キシ基、水酸基、ハロゲン原子または置換基を有してい
てもよいフェニル基を示し、nは0または1を示す)で
表される基、低級アルキル基で置換していてもよい炭素
数5〜8個のシクロアルキル基、ノルボルニル基または
ビシクロ[3.3.1]ノニル基を示し、pは0〜3の
整数を示し、C * は不斉炭素原子を示す〕で表される化
合物のカルボニル基を還元することを特徴とする一般式 【化5】 式中、mは0〜4の整数、C * は不斉炭素原子を示
し、Rは前記と同じ意味を 有する)で表されるアゼピン
誘導体またはその塩の製造法
4. A compound of the general formula [ Wherein R is a compound of the formula : ( Wherein R 1 is a hydrogen atom, a lower alkyl group, a lower alcohol
Having a xy group, a hydroxyl group, a halogen atom or a substituent
And n represents 0 or 1).
Carbon represented by the group represented by the lower alkyl group
5 to 8 cycloalkyl groups, norbornyl groups or
A bicyclo [3.3.1] nonyl group;
Represents an integer, and C * represents an asymmetric carbon atom.]
A general formula characterized by reducing the carbonyl group of the compound (In the formula, m is an integer of 0 to 4, C * represents an asymmetric carbon atom.
And R has the same meaning as described above )
Method for producing derivative or salt thereof
【請求項5】 一般式 【化6】 式中、C * は不斉炭素原子を示す)で表されるアミン
と一般式 X−(CH 2 )m−R式中、Rは 【化7】 式中、R 1 は水素原子、低級アルキル基、低級アルコ
キシ基、水酸基、ハロゲン原子または置換基を有してい
てもよいフェニル基を示し、nは0または1を示す)で
表される基、低級アルキル基で置換していてもよい炭素
数5〜8個のシクロアルキル基、ノルボルニル基または
ビシクロ[3.3.1]ノニル基を示し、Xは反応性有
機スルホニルオキシ基またはハロゲン原子を示し、mは
0〜4の整数を示す)で表される反応性誘導体を不活性
有機溶媒中、塩基の存在下で反応させることを特徴とす
る一般式 【化8】 式中、mは0〜4の整数、C * は不斉炭素原子を示
し、Rは前記と同じ意味を有する)で表されるアゼピン
誘導体またはその塩の製造法
5. A compound of the general formula ( Wherein C * represents an asymmetric carbon atom)
And the general formula X- (CH 2 ) m—R wherein R is ( Wherein R 1 is a hydrogen atom, a lower alkyl group, a lower alcohol
Having a xy group, a hydroxyl group, a halogen atom or a substituent
And n represents 0 or 1).
Carbon represented by the group represented by the lower alkyl group
5 to 8 cycloalkyl groups, norbornyl groups or
X represents a bicyclo [3.3.1] nonyl group;
A sulfonyloxy group or a halogen atom, and m is
Inactive reactive derivative represented by 0 to 4)
It is characterized by reacting in the presence of a base in an organic solvent.
The general formula (In the formula, m is an integer of 0 to 4, C * represents an asymmetric carbon atom.
And R has the same meaning as described above)
A method for producing a derivative or a salt thereof .
【請求項6】 一般式 【化9】 〔式中、Rは式 【化10】 (式中、R1 は水素原子、低級アルキル基、低級アルコ
キシ基、水酸基、ハロゲン原子または置換基を有してい
てもよいフェニル基を示し、nは0または1を示す)で
表される基、低級アルキル基で置換していてもよい炭素
数5〜8個のシクロアルキル基、ノルボルニル基または
ビシクロ[3.3.1]ノニル基を示し、pは0〜3の
整数を示し、C* は不斉炭素原子を示す〕で表されるア
ゼピン誘導体またはその塩。
6. A compound of the general formula [Wherein R is a compound of the formula: (Wherein, R 1 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group, a halogen atom or a phenyl group which may have a substituent, and n represents 0 or 1) A cycloalkyl group having 5 to 8 carbon atoms, a norbornyl group or a bicyclo [3.3.1] nonyl group which may be substituted with a lower alkyl group, p represents an integer of 0 to 3, and C * Represents an asymmetric carbon atom], or a salt thereof.
【請求項7】 1 が水素原子である請求項6記載のア
ゼピン誘導体またはその塩
7. The method according to claim 6, wherein R 1 is a hydrogen atom.
Zepin derivatives or salts thereof .
【請求項8】 (1S)−3−(2−アダマンチルアセ
チル)−1,8,8−トリメチル−3−アザビシクロ
[3.2.1]オクタンである請求項6または7記載の
アゼピン誘導体またはその塩
8. ( 1S) -3- (2-adamantyl acetyl
Tyl) -1,8,8-trimethyl-3-azabicyclo
[3.2.1] The method according to claim 6 or 7, which is octane.
An azepine derivative or a salt thereof .
JP22374593A 1992-09-18 1993-09-08 N- (cycloalkyl) alkylazepine derivatives and method for producing the same Expired - Fee Related JP2824381B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22374593A JP2824381B2 (en) 1992-09-18 1993-09-08 N- (cycloalkyl) alkylazepine derivatives and method for producing the same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP25015892 1992-09-18
JP4-250158 1992-09-18
JP4-267702 1992-10-06
JP26770292 1992-10-06
JP22374593A JP2824381B2 (en) 1992-09-18 1993-09-08 N- (cycloalkyl) alkylazepine derivatives and method for producing the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP20216695A Division JP2831952B2 (en) 1995-08-08 1995-08-08 Uses of N- (cycloalkyl) alkylazepine derivatives

Publications (2)

Publication Number Publication Date
JPH06172315A JPH06172315A (en) 1994-06-21
JP2824381B2 true JP2824381B2 (en) 1998-11-11

Family

ID=27330816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22374593A Expired - Fee Related JP2824381B2 (en) 1992-09-18 1993-09-08 N- (cycloalkyl) alkylazepine derivatives and method for producing the same

Country Status (1)

Country Link
JP (1) JP2824381B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025094A1 (en) * 1994-03-17 1995-09-21 Asahi Kasei Kogyo Kabushiki Kaisha Adamantylethylcamphidine derivative and use thereof
CA2274651A1 (en) * 1996-12-18 1998-06-25 Asahi Kasei Kogyo Kabushiki Kaisha Remedies/preventives for abnormal motions accompanying disorders in extrapyramidal system
EP4532668A1 (en) * 2022-05-31 2025-04-09 Symrise AG Ethyl 2-cyclooctylacetate as a fragrance

Also Published As

Publication number Publication date
JPH06172315A (en) 1994-06-21

Similar Documents

Publication Publication Date Title
EP0787723B1 (en) Cyclopropachromenecarboxylate derivatives
NZ240993A (en) 3,7-disubstituted indoles and analogues and pharmaceutical compositions
JPH06504042A (en) Method for producing substituted benzofuran derivatives
BR112012005511B1 (en) 5- (3,4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2,2-trifluoro-ethoxy -) - nicotinamide and salts thereof as cholesterol-raising agents hdl
JPH07500604A (en) Ethylalanine aminodiol compound for hypertension treatment
JP2824381B2 (en) N- (cycloalkyl) alkylazepine derivatives and method for producing the same
EP0724584B1 (en) Heterocyclic amines having central nervous system activity
US5658923A (en) Azepine derivatives and use thereof
JP2831952B2 (en) Uses of N- (cycloalkyl) alkylazepine derivatives
TW201302736A (en) Cathepsin C inhibitor
EP0661271B1 (en) Azepine derivatives, production thereof, and use thereof as sigma-receptor ligands
DE69306794T2 (en) ALKYLAMINO-ETHYNYL-ALANINE-AMINODIOL COMPOUNDS WITH IMIDAZOLYL / BENZIMIDAZOLYL END GROUP FOR THE TREATMENT OF HIGH BLOOD PRESSURE
JPH0285270A (en) Morpholine derivative
HK1000708B (en) Azepine derivatives, production thereof, and use thereof as sigma-receptor ligands
JP3233276B2 (en) Hydrazide compounds as kappa agonists
JPH11217361A (en) Naphthoquinone compound and medicine composed of the same
JP3142993B2 (en) Water-soluble benstatin derivatives and their pharmaceutical uses
WO1994008964A1 (en) N-phenethylazepine derivative and use thereof
US5650406A (en) Adamantane derivative, process for producing the same, and use thereof
JPH08198820A (en) Diadamantane derivative and its use
JPH06184113A (en) Azepine derivative, its production and use thereof
JPH083043A (en) Adamantane derivative, its production and use
US7074927B2 (en) Heterocyclic amines having central nervous system activity
JPH06157467A (en) 3-azabicyclo(3.2.1)octane derivative and use
JPH06211787A (en) N-phenetylazepine derivative and its use

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19980825

LAPS Cancellation because of no payment of annual fees